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GLOSSARY OF TERMS 
allotype - genetically inherited antigenic sites present on a 
class of antibodies in some individuals and absent from 
other individuals of the same species. 
antibody - immunoglobulin molecule produced by an animal's B 
lymphocytes in response to an antigenic stimulus and 
capable of binding to an antigen. 
Ab 1 - first antibody produced by an animal's B lymphocytes 
in response to the stimulus provided by an antigen. 
Ab 2 alpha - an antibody which recognizes an idiotope on Ab 1 
which is extraneous to the paratope of Ab 1. Ab 1/Ab 2 
alpha interactions are not antigen inhibitable. 
Ab 2 beta - an antibody (also known as a homobody, an 
internal image antibody or an antigen-mimicking antibody) 
which interacts with the paratope of Ab 1. Ab 1/Ab 2 beta 
interactions are antigen inhibitable. 
Ab 2 epsilon - an antibody (also known as an epibody) which 
interacts with an idiotope on Ab 1 and the antigen against 
which Ab 1 was derived. 
Ab 2 gamma - an antibody which interacts with an idiotope on 
Ab 1 which is closely associated with the paratope of 
Ab 1. Ab 1/Ab 2 gamma interactions are antigen 
inhibitable. 
Ab 3 - an antibody produced against Ab 2 which interacts with 
an idiotope on Ab 2. 
anti-idiotope antibody - an antibody which interacts with an 
idiotope of another antibody. 
anti-idiotype antibodies - polyclonal antibodies which intei— 
act with the antigenic sites (idiotopes) associated with 
an antibody's variable region. 
antigen - any substance which illicits an immune response in 
an animal. 
antigen-mimicking antibody - see Ab 2 beta. 
X 
autobody - an antibody with a paratope that reacts with an 
idiotope on the same antibody as well as with the antigen 
against which the antibody was generated. The self-
binding characteristics of an autobody are antigen 
inhibitable. 
constant region - portions of either the heavy or light chains 
of immunoglobulins which exhibit conserved amino acid 
sequences. 
cross-reactive idiotope (CRI) - an idiotope (also known as a 
public idiotope or IdX) which is shared by two or more 
antibodies which may or may not share similar antigenic 
specificities. 
epibody - see Ab 2 epsilon. 
epitope - a single determinant on an antigen. 
homobody - see Ab 2 beta. 
hypervariable region - portions of either the heavy or light 
chains of an immunoglobulin which exhibit extreme amino 
acid sequence variability and which make up part of the 
immunoglobulin's (antibody's) antigen combining site. 
idiotope - an antigenically distinct region associated with 
an immunoglobulin's paratope or hypervariable region. 
Idl (private idiotope) - an idiotope exhibited by only those 
antibodies derived from a common B lymphocyte. 
IdX (public idiotope) - see cross-reactive idiotope. 
idiotype - the total antigenic signature associated with an 
immunoglobulin's paratope or hypervariable region. 
immunoglobulins - gamma globulin molecules which demonstrate 
antibody activity. 
internal image antibody - see Ab 2 beta. 
isotype - the class or subclass of antibodies within a given 
animal species. 
lambda light chain - one of two antigenically distinct regions 
associated with the constant region of an immunoglobulin's 
light chain. 
x1 
kappa light chain - one of two antigenically distinct regions 
associated with the constant region of an immunoglobu lin's 
light chain. 
paratope - the antigen combining site of an 'immunoglobulin 
(antibody) molecule. 
private idiotope - see Idl. 
public idiotope (IdX) - see cross-reactive idiotope (CRI). 
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INTRODUCTION 
In 1974, Niels Jerne proposed the immune network theory 
to explain the outcome of an immune response in an anti-
genically stimulated animal. A fundamental premise of his 
theory involved the idea that antibodies (Ab 1), via their 
paratopes (antigen combining sites), recognized antigenic 
sites on foreign molecules and also recognized sites 
associated with the hypervariable regions of other antibodies 
(Ab 2). Since a site on Ab 2 could be recognized by the 
paratope of Ab 1, Ab 2 could theoretically mimic and replace 
the original antigen. Monoclonal antibodies (McAbs) which 
mimic a reovirus have, in fact, been generated. These McAbs 
recognized virus receptors on cells in tissue culture. 
Since viruses were first recognized as causative agents 
for some plant diseases, biological features, possibly 
receptors, which render some plants susceptible and others 
resistant to a particular virus have not been identified. 
It is quite possible that procedures used to label plant 
viruses, which were used as probes to identify virus recep­
tors, may inactivate virus structures responsible for virus 
attachment to plant cell receptors. Antibodies, on the other 
hand, can be labeled without destroying the biological 
properties associated with their hypervariable region. There­
fore, it may be possible to use a virus-mimicking McAb in lieu 
of a virus to successfully identify receptors on plant cells. 
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Since hybridotnas can produce a ready source of easily 
obtainable McAbs, a plant virus-mimicking McAb could be used 
as a positive control in immunoassays in place of the virus. 
This would be particularly advantageous in those cases where 
viruses a re difficult to purify or are subject to quarantine 
restrictions due to their exotic nature. 
The use of virus-mimicking McAbs represents a novel 
approach to research on plant viruses. Therefore, the 
following study was undertaken, using soybean mosaic virus as 
a model system, to develop and implement the use of such 
antibodies as potential research tools for the plant 
virologist. 
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LITERATURE REVIEW 
Since viruses were first recognized as the causative 
agents for some plant diseases, investigators have been unable 
to determine if virus receptors which render some plants 
susceptible and others resistant to a particular virus exist. 
Several studies have been done to determine the 
biological features responsible for virus specificity in 
plants. In an ultrastructural study, Gaard and DeZoeten (27) 
demonstrated end-on attachment of rod-shaped plant viruses to 
plant cell walls. This was followed by viral degradation and 
supposedly, release of RNA into the plant cell. However, this 
phenomenon was found to occur both in host and non-host 
plants. The plant cell wall did not appear to confer virus-
host specificity. This conclusion was also supported by the 
observations that viruses such as soybean mosaic (SMV) (12, 
30) and tobacco mosaic (TMV) (72) maintain host specificity 
even when the plant cell wall barrier is breached by 
mechanical means. 
In other studies, Shaw et al (101) and Wilson (123, 124) 
introduced evidence which indicated that TMV appeared to 
become intimately associated with ribosomes when mechanically 
introduced into cells of tobacco plants (101). When TMV 
particles reacted with the ribosomes, complexes referred to as 
"striposomes" were formed. The ribosomes removed the TMV coat 
protein in a process known as "cotranslational disassembly". 
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leaving the TMV RNA free to be translated (123, 124). 
Ribosomes may be the recognition site which confers virus 
specificity in plants; however, neither striposomes nor 
cotranslational disassembly has been demonstrated with viruses 
other than TMV. 
These studies have produced inconclusive results. 
Therefore, the biological features which confer virus 
specificity in plants remain unidentified. 
It is quite possible that the methods used to identify 
putative virus receptors in plants have been inadequate. 
Recently, a virus-mimicking monoclonal antibody (McAb), which 
has been categorized as an anti-idiotypic antibody (defined 
below), has been used to identify a mammalian reovirus 
receptor on vertebrate tissue culture cells (80). It is 
logical to speculate that similar plant virus-mimicking 
antibodies (Abs) may also prove useful in identifying virus 
receptors in plants. 
The concepts which support this approach can best be 
understood when the immunological properties and binding 
characteristics of an Ab molecule are defined either iji vitro 
or iji vivo with respect to other immunoreactive molecules. 
Antibodies are immunoglobulin molecules produced by an 
animal's B lymphocytes in response to an antigenic stimulus. 
Each molecule has two or more antibody-combining sit.es termed 
paratopes. A paratope is capable of recognizing a single 
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antigenic determinant known as an epitope (47). 
There are five classes (IgG, IgM, IgA, IgD and IgE) and 
eight subclasses (IgGl, IgG2, IgG3, IgG4, IgMl, IgM2, IgAl and 
IgA2) of Ab molecules which can be immunologically identified 
with anti-isotype (anti-class or anti-subclass) Abs directed 
to unique immunoglobulin heavy chain constant regions. 
Antibodies directed to other antigenically distinct constant 
regions on an immunoglobulin molecule can also be used to 
determine an immunoglobulin's light chain (lambda or kappa) or 
allotypic characteristics. Allotypic characteristics are 
genetically inherited antigenic sites present on a class of 
Abs in some individuals and absent from other individuals of 
the same species (113). 
Antibodies directed to antigenically distinct regions 
associated with an immunoglobulin's paratope or hypervariable 
region define an immunoglobulin's idiotype. Each epitope 
within an idiotype is termed an idiotope (47). Idiotypes were 
first described by Kunkel et al (63) and Oudin and Michel 
(82), and the Abs directed against these regions were termed 
anti-idiotype Abs (83). These Abs do not recognize the 
antigenically distinct constant regions associated with either 
an immunoglobulin's isotype or allotype (58). 
In 1974, Jerne, prompted by the previous work done on 
i diotype/anti-idiotype ijn vitro and i_ii vivo interactions, 
established the immune network theory to explain the outcome 
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of the immune response in antigenica11 y stimulated animals. 
This theory describes the immune system as a complex network 
of paratopes that recognize epitopes on foreign molecules, as 
well as idiotopes on self molecules (47). 
Jerne envisioned that in an antigen free system, Ab 
production by B cells is suppressed via the equilibrium 
imposed through idiotype/anti-idiotype interactions. 
According to his theory, the essence of the immune system 
is repression of lymphocyte production by anti-idiotype Abs. 
Jerne used the following example to describe this phenomenon. 
When an antigen is introduced into an animal's immune 
system, the paratope of an Ab (Ab 1) interacts with the 
antigen, and Ab 1 is removed from the equilibrated immune 
system. Since the interaction between the paratope of Ab 1 
and the idiotope of Ab 2 molecules (termed internal image, or 
antigen mimicking, or anti-idiotype Ab 2 beta) (60) can no 
longer occur, the suppressive effects exerted by Ab 1 on B 
cell production of Ab 2 beta are removed. Idiotopes on Ab 1, 
which stimulate B cell production of other Ab 2 molecules 
(termed anti-idiotype Ab 2 alpha) (60), are no longer present, 
and B cell Ab 2 alpha production and concentration are 
reduced. B cells bearing Ab 2 beta can now proliferate in the 
absence of Ab 1. In the absence of the antigen, an increase 
in Ab 2 beta concentration will stimulate an increase in B 
cell Ab 1 production which in turn stimulates an increase in 
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Ab 2 alpha production. Increases in Ab production will 
continue until an idiotype/anti-idiotype equilibrium is again 
reached (47, 49, 88). 
Jerne also predicted that paratopes on some anti-idiotype 
Abs will also recognize the idiotopes on other Abs which are 
not specific for the original antigen. This concept was used 
to explain the production of unspecific immunoglobulins often 
observed after an immunogenic stimulus (47). 
The features described by Jerne's network theory have 
prompted others to investigate the extent to which Abs 
interact with one another and their immunological impact on an 
animal's immune system. 
Anti-idiotope Abs are characterized on the basis of 
1) their interactions with idiotopes on other Abs from the 
same animal species or from different species; 2) their 
interactions with idiotope-presenting Abs in the presence of 
competing antigens; and 3) their i]i vivo biological activity. 
Interactions with idiotopes on other Abs. Abs on B cells 
recognize a wide variety of idiotopes on Abs from intrastrain, 
interstrain and interspecies animals (8). Shared idiotopes 
among Abs are referred to as either public idiotopes (IdX) or 
cross-reactive idiotopes (CRIs) (43, 76). Those idiotopes 
which are not shared by immunoglobulins are termed private 
idiotopes (Idl) (10). 
The following examples illustrate situations where anti-
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idiotypic Abs interacted with intrastrain and/or interstrain 
CRIs on other Abs. 
Monoclonal anti-idiotypic Abs interacted with intrastrain 
and interstrain CRIs on different mouse McAbs which were 
specific for different immunodominant sugars on Escherichia 
CO 1 i, Salmonella tranora, Salmonella telaviv and Proteus 
mi rabi1i s (40). 
In another situation, guinea pig anti-idiotype polyclonal 
Abs interacted with CRIs on two McAbs which were distinct for 
different epitopes on hen egg white lysozyme (76). 
Anti-idiotypic Abs have also been found to interact with 
CRIs present on different McAbs to distinct influenza virus 
epitopes. Some of these anti-idiotypic Abs also interacted 
with CRIs present on different Abs specific for either natural 
or variant strains of influenza virus (66). 
Interactions between anti-idiotypic Abs and intrastrain 
Ab CRIs have been described for several other antigen-antibody 
systems (2, 9, 10, 13, 43, 65, 69, 95, 121). Interactions 
between anti-idiotypic Abs and CRIs present on and shared,by 
Abs from different animal species havs also been reported (13, 
59, 81, 95, 102). For example, anti-idiotype Abs interacted 
with a CRI present on mouse, rat, deer mouse and rabbit Abs 
which were generated to hen egg white lysozyme (78). Anti­
idiotype Abs also interacted with a CRI present on rat and 
human Abs to thyrog1obu1in (125). In still another instance. 
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an anti-idiotope McAb to a poliovirus Ab interacted with a CRI 
present on poliovirus Abs from different animal species (117). 
The genetic basis for the interactions between an anti-
idiotope Ab and CRIs on Ab to different antigens has been 
traced to the CRI Ab producing cell. Different cells which 
produce Abs that express CRIs also have similar DNA sequences. 
Hornbeck and Lewis (43), Rajewsky and Takemori (86) and Victor-
Korbin et al (121) have demonstrated that the expression of a 
CRI by an Ab producing cell is controlled by Ab structural 
genes. These genes may be located on either one or the other 
or both variable chain region DNA segments. 
Serological, amino acid and genetic analysis of other 
cells producing recurrent idiotopes has also correlated CRI 
expression with variable region gene sequences (13, 69, 94, 
104). 
Victor-Korbin and his coworkers demonstrated that 
different hybridomas which produced McAbs to either arsenate 
or nitrophenyl hapten or dextran shared similar, although not 
identical, variable heavy chain region DNA sequences. These 
hybridomas all produced McAbs with a common idiotope. A 
comparison of the amino acid sequences of some of these McAbs 
with different antigenic specificities suggested that the 
structural basis for the common idiotope's antigenicity was 
due to its three-dimensional configuration. This conclusion 
was based upon the fact that the primary amino acid sequences 
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encoded by the variable heavy chain DNA did not yield a common 
structural correlate (121). Based on this information, the 
following hypothesis can be made. If the antigenicity of an 
idiotope is due to its tertiary rather than its primary 
s t r u c t u r e ,  t h e n  s l i g h t  d i f f e r e n c e s  i n  t h e  p r i m a r y  a m i n o  a c i d  
sequences for similar but different idiotopes may be 
overlooked by an anti-idiotope Ab in favor of the overall 
idiotope tertiary structure. If this is the case, then this 
would explain why some anti-idiotope Abs interact with several 
different Abs. 
Although the immune network theory was originally 
described to explain interactions between Ab producing B cell 
clones, it has been extended to include interactions with T 
cells, such as T helper (TH) cells and T suppressor (TS) cells 
which respectively can enhance or suppress an immune response 
to an antigen (23, 32). Idiotopes (9, 25, 86) and anti-
idiotopes (8, 43) are expressed on antigen receptors of T 
cells which can participate in immune regulation (9). 
The following examples describe situations where T cells 
exhibit either idiotypic or anti-idiotypic characteristics. 
Anti-idiotypic Abs produced in guinea pigs against an Ab 
specific for Group A streptococci carbohydrate sensitized mice 
against the carbohydrate. When TH cells induced by the guinea 
pig anti-idiotypic Abs were isolated from the sensitized mice, 
they were found to exhibit specificity for streptococci (22). 
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This implied that the idiotope on the Group A streptococci 
specific Ab was similar to idiotopes on the TH cells. 
In another situation, adult rats inoculated with T cells 
specific for alloantigens produced Abs (anti-idiotypes) 
against idiotope determinants present on IgG alloantibodies 
with the same antigenic specificity as the T cells used as 
inoculum (4). Apparently, the T cells exhibited idiotopes 
similar to those present on IgG alloantibodies. 
Other studies have involved Balb/c mice inoculated with 
the hapten trinitrophenyl (TNP) conjugated to various 
carriers. These mice secreted Abs bearing the idiotope known 
as 460 Id. _In vitro, the number of B cells responding to TNP 
and expressing the 460 Id were greater when B cells were 
cultured alone than when B cells were cultured with T cells 
from the same animal. Some of the T cells in this system 
apparently were anti-idiotypic TS cells since they suppressed 
the 460 Id B cell response to TNP (5). T cells responding to 
idiotopes or anti-idiotopes have also been described in other 
immunological situations (10, 21, 23, 25, 39, 51, 60, 70, 86, 
95). 
Viewed collectively, T cells and Ab secreting B cells 
appear to serve as sites for immune regulation (9) and can 
either enhance or suppress an immune response when stimulated 
with an appropriate antigen or antibody. 
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Anti-idiotope Ab interactions with idiotope bearing Abs 
in the presence of a competing antigen. Interactions between 
an anti-idiotope Ab (Ab 2) and the idiotope on one or more Abs 
(Ab 1) are used to characterize an anti-idiotope Ab. The 
topographical location of the recognized idiotope on the 
surface of an Ab 1 with respect to its paratope can then be 
used to further characterize the anti-idiotope Ab. Based on 
the location of the idiotope recognized by the anti-idiotope 
Ab, four or possibly five different categories of anti-
idiotypic Abs can be described. 
Four of the categories of anti-idiotypic Abs, which are 
given Greek letter designations, include Ab 2 alpha, Ab 2 
beta, Ab 2 epsilon and Ab 2 gamma (31, 49, 60, 88, 115). A 
fifth class of Ab, which may or may not be considered anti-
idiotypic in nature, is termed an autobody (52, 53, 60). 
Distinctions between different types of anti-idiotypic 
Abs are initially based upon i_n vitro competition assays 
involving the idiotope bearing Ab, the anti-idiotope Ab and 
the antigen. 
Anti-idiotypic Abs designated Ab 2 alpha recognize 
idiotopes on the variable regions of another Ab that are 
spatially removed from the paratope of that Ab. Consequently, 
idiotope/Ab 2 alpha interactions are not inhibited by the 
antigen (60, 88). Generally, Ab 2 alpha anti-idiotypic Abs 
administered in. vivo suppress Ab production by B cells which 
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exhibit an idiotope recognized by Ab 2 alpha (47, 49). 
Anti-idiotypic Abs referred to as Ab 2 beta are also 
known as internal image Abs (47, 50, 59, 67), antigen-
mimicking Abs (126) or homobodies (7, 8, 59). These anti-
idiotypic Abs interact with the paratope of another Ab, and 
this interaction is inhibited by the antigen. When Ab 2 beta 
is introduced into animals previously unexposed to the 
original antigen, Ab 2 beta can stimulate the production of Ab 
3. This Ab will have antigen binding characteristics similar 
to those displayed by the original idiotope bearing Ab (Ab 1) 
(126). 
Abs referred to as Ab 2 gamma recognize idiotopes in or 
near the paratope of another Ab molecule. Therefore, the 
idiotope/Ab 2 gamma interactions are sterically hindered by 
the antigen (60). It is difficult to discriminate between Ab 
2 beta and Ab 2 gamma anti-idiotype Abs with in. vitro 
immunoassays. Sometimes an anti-idiotope Ab can only be 
categorized as Ab 2 beta when it mimics the antigen and 
recognizes the same biological features as the antigen, such 
as antigenic receptors (31). 
Ab 2 epsilon represents a fourth category of anti-
idiotypic Abs, which were first described by Bona and his 
coworkers (7). These investigators found that when mice were 
injected with a human McAb (Ab 1) with anti-gamma globulin 
activity, some of the anti-idiotypic McAbs interacted with an 
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idiotope on Ab 1 and an epitope on the antigen. The Ab 1/Ab 2 
epsilon interaction was also partially inhibited by the 
antigen. The term epibody was coined to designate those anti-
id iotypic Abs which interacted with the idiotope on Ab 1 and 
with the antigen used to induce Ab 1, 
Abs which bind to the antigen and to themselves are 
termed autobodies (53). Autobody characteristics were first 
ascribed to an anti-Tl5 idiotope IgM McAb (Ab 2). This Ab 
interacted with the T15 idiotope on an IgA McAb (Ab 1) to 
pneumococcal antigen and also with the antigen. The Ab 
further demonstrated self-binding properties which were 
antigen inhibitable. It was later discovered that the anti-
pneumococcal T15 idiotope bearing McAb (Ab 1) was also self-
binding, and this self-binding was again antigen inhibitable 
(52). Since, in this situation, Ab 1 and Ab 2 both exhibited 
self-binding characteristics, autobodies may be considered a 
special category of Abs in general rather than a category of 
anti-idiotypic Abs. 
In the literature, anti-idiotypic Abs which mimic 
antigens are generally placed in the Ab 2 beta category since 
biological properties which distinguish them from Ab 2 gamma 
have been determined. In the absence of pertinent information 
concerning the biological properties of an anti-idiotope Ab, 
the Ab is described on the basis of its vitro interactions 
with idiotope bearing Abs in the presence or absence of the 
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antigen rather than being assigned to the Ab 2 alpha or gamma 
category. 
Anti-idiotypic Ab vivo biological activity. Anti-
idiotypic Abs introduced into an animal previously unexposed 
to an antigen can either effectively suppress or enhance an 
immune response to the antigen. These effects have been 
reported and the following examples illustrate situations 
where anti-idiotypic Ab modulation of the immune response has 
occurred. 
Numerous studies have shown that i_n. vi vo administration 
of anti-idiotypic Abs can provoke suppression of the immune 
response (9, 23, 39, 54, 55, 56, 79, 87, 89). In one study, 
Aguis and Richman (2) used anti-idiotypic Abs to suppress 
myasthenia gravis in rats. When rats were injected with 
isogeneic anti-idiotypic McAbs to anti-acetylcholine receptor 
McAbs and then immunized with acetylcholine receptor proteins, 
Ab production to the acetylcholine receptor was suppressed. 
Rats not exposed to the anti-idiotypic Abs produced Abs to the 
acetylcholine receptor and demonstrated symptoms character­
istic of myasthenia gravis. 
In another study, Kearney and his coworkers (54) 
demonstrated that when an anti-idiotope McAb specific for an 
Id I on an anti-dextran Ab was administered to mice, it 
suppressed only those Id I bearing Abs when the mice were 
subsequently challenged with dextran. In contrast, an anti-
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idiotope McAb specific for IdX on anti-dextran Abs suppressed 
the overall anti-dextran Ab response. 
Anti-idiotypic Ab modulation of the immune response has 
also been reported by Victoi—Korbin and his colleagues (121). 
In their studies, mice were challenged with dextran and the 
hapten, 4-hydroxy-3-nitropheny1 (MP), after having been 
previously exposed neonatally to an anti-idiotope Ab 
recognizing a CRI on anti-dextran and anti-NP McAbs. These 
mice exhibited suppressed anti-dextran and anti-NP Ab 
production. 
Anti-idiotypic Abs can also enhance an immune response to 
an antigen and, in some instances, can even act as a vaccine 
to replace the antigen. Urbain (115) described a situation 
where mice injected with rabbit anti-idiotype Abs to rabbit 
anti-TMV Abs produced Abs to TMV without ever having been 
exposed to the virus. In another study, mice injected with an 
anti-idiotope McAb to an idiotope on a TH cell clone specific 
for Sendai virus were protected when challenged with a lethal 
dose of the virus (23). The work of Kennedy and his 
colleagues (58) demonstrated the protective effect of anti­
idiotype Abs in chimpanzees challenged with hepatitis type B 
virus (HBV). If the chimpanzees were pre-immunized with 
rabbit anti-idiotype Abs to human anti-HBV Abs, they were 
protected, while those animals not receiving the Abs developed 
symptoms of the disease. 
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In viVP administration of appropriate anti-idiotypic Abs 
has also induced protection in animals against rabies virus 
(87), reovirus (100), poliovirus (117), Newcastle disease 
virus (108), Escherichia coli (106), Streptococcus pneumoniae 
(74), African trypanosomiasis (96) and Schi stosoma manson i 
(35). 
The usefulness of anti-idiotypic Abs as vaccines is 
apparent in situations where attenuated pathogens may undergo 
antigenic drift to escape a host's defense system. Generally, 
Abs specific for different pathogen subtypes share CRIs. An 
anti-idiotope which recognizes appropriate B or TH cells could 
stimulate protection against a wide range of pathogenic sub­
types whereas an attenuated pathogen displaying the antigenic 
attributes of one subtype would not (6). 
Although anti-idiotypic Abs can replace some traditional 
antigenic vaccines, their use is limited. Some animals 
receiving anti-idiotypic Abs are genetically restricted and 
cannot produce an appropriate protective Ab response (116). 
As immunogens, anti-idiotypic Abs demonstrate a dose-dependent 
effect and can either enhance or suppress an animal's immune 
response to an antigen (3, 79). Finally, prior i_n^ vivo 
administration of anti-idiotypic Abs may actually enhance the 
severity of a disease, as has been demonstrated with the 
herpes simplex virus 2 idiotope/anti-idiotype system in 
experimentally infected mice (57). 
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Since some anti-idiotypic Abs immunologically resemble the 
antigens themselves, they can be used to identify antigenic 
receptors on cells. In studies with reovirus, a syngeneic 
anti-idiotope McAb to an anti-reovirus McAb identified a cell 
surface receptor for the virus (80). Anti-idiotypic Abs have 
also been used to identify insulin receptors on rat thymo­
cytes. In these studies, xenogeneic rabbit polyclonal anti­
idiotype Abs to insulin specific rat Abs bound to rat 
thymocyte cells and mimicked insulin by stimulating amino-
isobutyric acid uptake in these cells (97). Finally, rabbit 
anti-idiotype Abs to rat anti-thyroid stimulating hormone 
(TSH) Abs bound to purified thyroid plasma membranes and also 
mimicked the biological effects of TSH on thyroid cells (31). 
Anti-TSH anti-idiotypic Abs have also been used to biochemi­
cally characterize the TSH receptors. 
Although antigen mimicry is a characteristic of some anti-
idiotypic Abs (36, 67), it does not appear to be a universal 
property. For example, in the Coxsackie virus system, three 
different rabbit anti-idiotype preparations to three different 
McAbs which neutralized the virus failed to recognize virus 
receptors on monkey kidney cells. It was suggested that the 
rabbit anti-idiotype Abs may not have been stereochemically 
suited for recognition of the receptor binding site in the 
cell. These rabbit anti-idiotype Abs, which were generated to 
the Fab fragments of the Coxsackie virus McAbs, also failed to 
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induce a virus-neutralizing Ab 3 response in mice (73). 
Consequently, they may not have been antigen mimicking Abs. 
The purpose of this study was to determine if anti-
idiotypic Abs could mimic plant viruses and thus identify 
putative virus receptors in plants. Since this approach had 
never been attempted with a plant virus, the problems 
associated with such a study, from an immunological point of 
view alone, could not be predicted. Logically, it was 
necessary to choose a plant virus that was easy to obtain and 
work with, biologically well characterized and agriculturally 
significant. SMV fulfilled these criteria and was therefore 
used as a model system to generate plant virus mimicking anti-
id iotypic Abs. 
SMV is a virus which infects soybeans (Glycine max) and 
other members of the plant family Leguminosae (12, 29) as well 
as weeds common to soybean fields (85). A variety of SMV 
isolates have been identified on the basis of their patho­
genicity to differential soybean cultivars (14). 
The virus is a long flexuous rod measuring 680 to 900 by 
n nm (24, 38) with a modal length of 685 to 750 nm (12) 
and a molecular weight of 6.13 x IG^daltons (42). The capsid 
is made up of multiple copies of a single protein of 28,000 to 
36,000 daltons (41). Five percent of the virion consists of a 
positive-sense single-stranded ribonucleic acid (RNA) molecule 
with a molecular weight of 2.8 to 3.5 x 10® daltons (38, 42). 
2 0  
The RNA codes for viral coat protein (119) and probably other 
viral products, such as the cylindrical inclusion bodies found" 
microscopically in infected plant tissue (20). 
SMV infected plants commonly exhibit vein clearing and 
mosaic symptoms (12). However, SMV will induce a variety of 
disease symptoms (61, 122) depending on cultivar, plant age at 
the time of infection (90), virus strain (91, 93) and 
environmental conditions such as light (92) and temperature 
(12, 18, 84, 92). Factors such as time, location, cultivar 
and SMV strain may reduce yields, as determined from 
experimentally infected plants, by 8 to 93 percent (109). 
SMV infected plants also exhibit a variety of 
physiological and biochemical changes in nodulation and 
nitrogen fixation (110, 111, 112), maturity, and free acid 
(37, 112), starch, lipid (64) and seed oil content (17). 
The virus is primarily spread from one geographical 
region to another via infected seed (33, 34). However, it can 
also be spread through mechanical means (12, 30) and through 
insect vectors, notably aphids (12, 15, 16, 45, 68). 
Although nearly all varieties of soybeans in the United 
States are susceptible to SMV (45), its spread can be 
controlled through the use of virus-free seed, soybean 
cultivars resistant to SMV and cultivars resistant to seed 
transmission (103). 
The following study describes the approaches used to 
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generate and identify anti-idiotypic Abs to mouse anti-SMV 
McAbs and rabbit anti-SMV polyclonal Abs. The impact of some 
of these anti-idiotypic Abs on SMV lesion formation in plants 
or on Ab production in rats is also discussed. 
2 2  
MATERIALS AND METHODS 
Origin of Virus Antigens and Idiotype Antibodies 
The antigens, SMV isolate la 75-16-1, tobacco ringspot 
virus (TRSV), TMV, maize dwarf mosaic virus strain A (MDMV-A), 
barley yellow dwarf virus strain R.P.V. (BYDV), protein 
A purified polyclonal rabbit Abs to SMV (SMV Ab), TRSV 
(TRSV Ab), and BYDV (BYDV Ab), and MAGI I (an IgG2a kappa 
light chain McAb to MDMV-A), were supplied by Dr. John Hill, 
Iowa State University, Ames, Iowa. 
Newcastle's disease virus (NOV), the IgG2a kappa anti-SMV 
secreting hybridomas SI and S2, protein A purified McAbs 
NDV3H4 and NDV4F11 (IgG2a kappa McAbs to NDV) and protein A 
purified biotinylated SI were obtained from Dr. Donald P. 
Durand, Iowa State University. 
Production of Antibody-Secreting Hybridomas 
Antibody-secreting hybridomas were generated according to 
the procedure of Van Deusen and Whetstone (120). Modifica­
tions of their techniques and the reagents and media used in 
this study are described below. SP2/0-Ag 14 (SP2/0), the 
established cell line used for all fusion events, was donated 
by R. A. Van Deusen, Iowa State University. 
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Dulbecco's modified Eagle's medium (DMEM) 
DMEM was used for the propagation of all myeloma cells. 
It was prepared by combining one package of DMEM (Gibco 
Laboratories, Grand Island, NY; #430-21001), 18.5 g NaHCO^, 
36.0 g HEPES (Sigma Chemical Co., St. Louis, MO; #H3375) and 
double distilled water to 5 liters. The double distilled 
water was generated by passing distilled water through a Supei— 
Q Ultra Pure Water system (Millipore Corp., Bedford, MA). 
This water source was used for all protocols requiring water 
as a diluent. The medium was filtered through a sterile 
Gelman 0.2 ;um filter (Allied-Fisher Scientific, Chicago, IL; 
#09-730-241G) and stored in 500 ml aliquots at either 4 C or 
-20 C. A mixture of 2 parts horse serum (Gibco; #230-6050) 
and 1 part calf serum (Gibco; #230-6170) was added to the 
medium as described below. 
100X L-qlutamine 
L-glutamine, an amino acid necessary for myeloma cell 
viability, was a labile component in reconstituted unfrozen 
DMEM. It was therefore necessary to supplement the medium 
every 2 weeks with L-glutamine. A 100X solution of the amino 
acid was prepared by dissolving 2.92 g of L-glutamine (Sigma; 
#63126) in 100 ml of water and filter sterilizing through a 
0.2 jum Nalgene syringe filter (Fisher; #09-740-35A). The 
solution was stored at -100 C in 2.0 ml aliquots. 
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Regular growth medium (DMEM-R) 
The medium was prepared by adding 50 mg of gentamicin per 
liter and serum to a final concentration of 10% in DMEM. 
DMEM-R was used to culture all established cell lines in this 
study. Unfrozen DMEM-R was supplemented with lOOX L-glutamine 
every 2 weeks. 
8-azaquanine medium (DMEM-8-aza) 
Aminopterin was used to selectively eliminate established 
SP2/0 cells which h ad failed to fuse with spleen cells to form 
hybridomas. Elimination of SP2/0 cells which had mutated to 
aminopterin resistance was accomplished by exposing them for 1 
week to DMEM containing 2.0 mg of 8-azaguanine (Sigma; #A8526) 
per liter. This procedure was performed at least 1 to 2 
months prior to fusion. DMEM-8-aza was prepared by adding 2.0 
mg of 8-azaguanine to 1 liter of water and incubating at 37 C 
overnight with stirring. This solution was then used in lieu 
of water to prepare DMEM. 
Conditioned medium (CM) 
The supernatant from SP2/0 cells which had grown in 
DMEM-R for 2 to 3 days was collected by centrifugation at 
225xg for 10 min. This supernatant, known as CM, was used in 
lieu of cell feeder layers (107). 
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Phosphate buffered saline 
Unless stated otherwise, the PBS used throughout this 
study was prepared by titrating a solution containing 13.6 g 
of KHgPO^ and 8.5 g of NaCl in 1 liter of water against a 
solution containing 17.4 g of K2HPO4 and 8.5 g of NaCl in 1 
liter of water until a pH of 7.1 was reached. 
Cell viability stain 
A 0.08% solution of trypan blue (Allied Chemical, New 
York, NY; #508) in PBS was used to differentiate viable cells 
which remained unstained from nonviable cells which stained 
blue. Viable cell counts were performed with a hemocytometer 
(AO Instrument Co., Buffalo, NY). 
Polyethylene glycol 1000 (PEG-1000) 
The cell fusing agent, PEG-1000 (Hazelton-Dutchland Inc., 
Denver, CO; #59-90739), was prepared by dissolving 2.25 g of 
PEG-1000 in 2.7 ml of pH 8.1 PBS at 60 C and sterilizing the 
solution through a 0.2 ijm syringe filter (99). 
Cloning-thawing medium (DMEM-CT) 
DMEM-CT was prepared by mixing 20 ml of serum, 30 ml of 
DMEM, 50 ml of CM, 1.0 ml of lOOX L-glutamine and 5.0 jjg of 
gentamicin. This solution was used to thaw frozen cells and 
clone mixed hybridomas. 
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Hypoxanth1 ne-aminopterin-thymidine medium (HAT) 
HAT medium, which was used to select for SP2/0 cells 
successfully fused with spleen cells, was prepared by adding 
lOOX HAT solution (Hazelton; #59-77076) to DMEM-CT (28). 
Cell freezing medium 
All cells which were stored frozen were first suspended 
in cell freezing medium consisting of 10% dimethyl sulfoxide 
(DMSO) (Sigma; #0-2650) in serum. 
Growth and maintenance of SP2/Q cells 
SP2/0 cells were grown in DMEM-R and transferred to fresh 
medium every 5 to 7 days when passaged at a 1:500 dilution or 
every 3 to 4 days when passaged at a 1:20 dilution. SP2/0 
cells used for fusions were passaged at a 1:20 dilution. All 
cells were maintained in a 37 C humidified incubator under a 5 
to 7% COg atmosphere. 
General scheme for ascites production 
Ascites fluid was induced in Balb/c mice by intraperi­
toneal inoculation with hybridoma cells. Cells, which 
were grown in DMEM-R, were first centrifuged at 250xg and 
washed several times with PBS. Approximately 3 x 10^ viable 
cells were then injected into each of several mice (Jackson 
Labs, Bar Harbor, ME) which had been primed at least 1 week 
earlier with 0.5 ml of pristane (Sigma; #T7640). When the 
abdomens of the mice were distended with ascitic fluid, they 
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were tapped with an 18 gauge needle (Fisher; #14-826-50). 
Collected ascites fluid, which contained a high concentration 
of hybridoma Ab, was frozen at -20 C until used. 
Protein A purification of SI IqG from mouse ascites 
IgG from mouse ascites was affinity purified using a 
protein A sepharose CL-4B (Sigma; #P3391 ) column equili­
brated to pH 8.2 with O.IM phosphate buffer (1:5 dilution 
of a 0.5M, pH 8.2 phosphate buffer containing 68.1 g 
MagHPO^, 2.72 g KHgPO^, 2.0 g NaNg, and water to 1 liter). 
Five ml of ascites fluid was equilibrated to pH 8.2 by adding 
1.25 ml of 0.5M, pH 8.2 phosphate buffer. The fluid was 
partially clarified by centrifugation at 500xg and applied to 
the protein A column. The column was then rinsed with several 
bed volumes of O.IM, pH 8.2 phosphate buffer. An eluting 
solution was prepared by mixing 0.5 ml glacial acetic acid, 
4.5 g NaCl, 0.2 g NaNg, and water to 500 ml. The pH was 
adjusted to 3.0 with l.ON NaOH. Acidic IgG fractions (2.0 ml 
volumes) were eluted from the column and collected in tubes 
containing 0.8 ml of O.IM, pH 9.0 Tris-HCl buffer. The Tris 
buffer was prepared by mixing 1.52 g Trizma HCl and 10.94 g 
Trizma base in 1 liter of water and adjusting the pH to 9.0 
with l.ON NaOH or l.ON HCl. As with all IgG preparations, 
protein concentrations of the IgG fractions were estimated 
spectrophotometrical 1 y at 280 nm (extinction coefficient = 1.4 
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for a 0.1% protein solution). IgG fractions were stored 
either at -20 C (long term) or at 4 C (short term). 
G1utaraIdehyde fixation of SI hybridoma cells 
Twenty to 30 ml of 31 hybridoma cells (approximately 3 to 
5 X 10^ cells), which had been growing in DMEM-R, were rinsed 
several times with PBS and fixed for 15 min with 25 ml of PBS 
containing 1 % g 1utara1dehyde (Polysciences, Warrington, PA; 
#1909). The cells were pelleted and resuspended in 50 ml of 
0.2M glycine for 2 hr to block any remaining free aldehyde 
groups. The cells were then pelleted, resuspended in PBS 
containing 0.02% sodium azide, and refrigerated until used. 
Cells stored in PBS containing azide were rinsed briefly with 
azide-free PBS prior to their injection into mice (36). 
Immunization of mice with SI 
A Balb/c mouse was immunized with SI according to the 
following schedule. On day 0, the mouse was injected 
intraperitoneally (IP) with 2.5 x 10^ glutaraldehyde fixed SI 
hybridoma cells in PBS emulsified 1:1 (v/v) with Freund's 
complete adjuvant (Sigma; #F-588). On day 19, an IP injection 
g 
of 5 x 10 cells in PBS was administered (36). This was 
followed on day 33 with an IP injection of 55 ug of protein A 
purified SI diluted in PBS. The last 2 injections of SI were 
given on days 83 and 86 and consisted respectively of 25 jug 31 
injected intravenously (IV) in the tail vein and 50 jjg divided 
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equally between IP and IV routes. The mouse was sacrificed 3 
days following the final injection, and its spleen cells were 
removed for use in fusion experiments. 
Immunization of mice with rabbit Abs 
Balb/c mice were injected IP on day 0 with 50 ^ g of 
rabbit TRSV Ab in PBS and with 3.75 mg of cyclophosphamide 
(Sigma; #C-7397) diluted in PBS. Cyclophosphamide was added 
to chemically induce immune tolerance to common rabbit Ab 
epitopes (98). Two weeks later, the mice were injected with 
50 ug of  rabbit SMV Ab in PBS emulsified 1:1 (v/v) with 
Freund's complete adjuvant. During the fourth week, mice 
received 50 jug of SMV Ab in PBS emulsified 1:1 (v/v) with 
Freund's incomplete adjuvant (Sigma; #F-5506). Injections 
of 50 ;ug of SMV Ab in PBS were then given during weeks 6, 7, 
8 and 9. Three days prior to being sacrificed during week 
14, the mice received a final injection of 50 to 100 ^ g of 
SMV Ab. 
Immunization of rats with anti-idiotype cells and/or ascites 
Two pairs of ovaricized rats were inoculated with anti­
idiotype cells and/or ascites fluid to determine if the anti­
idiotype could mimic the SMV antigen and thus elicit an immune 
response against it. Prior to inoculation, the rats were bled 
(0.2 ml) intracardially. On those occasions when the blood 
clotted rapidly, it was diluted with PBS. After each 
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bleeding, blood was transferred to micro-centrifuge tubes 
(USA/Scientific Plastics Inc., Ocala, FL; #USA-505) and 
centrifuged for 2 mi n in a Beckman Microfuge B. The 
supernatant was collected and stored frozen until needed. 
One pair of Long Evans rats were injected with anti­
idiotype la ascites fluid emulsified 1:1 (v/v) with Freund's 
complete adjuvant on day 0. The rats were bled and injected 
with 0.1 ml of la ascites on days 14 and 25. Rats were 
decapitated on day 35 and 2 ml s of blood was collected from 
each. 
The protocol used for glutaraldehyde fixation of SI 
hybridoma cells was also used to fix anti-idiotope 3 hybridoma 
cells. On days 0 and 20, approximately 2 x 10^ cells and 
2 X It) ^  cells diluted in PBS were respectively injected into 
each of two Fisher 344 rats. The rats were rested for three 
weeks and then injected with 0.1 ml of anti-idiotope 3 ascites 
on days 47 and 61. On day 70, the rats were bled and injected 
with 0.1 ml of ascites. Nine days later, the rats were 
decapitated and 2 mis of serum was collected from each rat. 
Cell fusion protocol 
For cell fusion experiments, mice used to generate SI 
ascites or mice hyperimmunized 3 days prior to the fusion were 
exsanguinated via cardiac puncture. The mouse carcass was 
rinsed thoroughly with 70% ethanol (ETON) in water and placed 
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dextrally on the floor of a Biogard laminar flow hood (Baker 
Co. Inc., Biddefordi MA) for splenectomy. The spleen was 
aseptically removed and placed in a 60 x 15 mm Corning tissue 
culture dish (Fisher; #08-772-21) containing several ml of 
DMEM. It was cut into 2 to 4 pieces, each of which was 
perfused with 1 to 2 ml of DMEM by using a syringe and needle. 
The resulting cell suspension, excluding the spleen connective 
tissue, was added to a 50 ml Corning polypropylene tube 
(Fisher; #05-538-55) containing 3.5 to 4.5 x 10^SP2/0 cells. 
The SP2/0 and spleen cells were centrifuged at 400xg for 8 
min. The supernatant was then discarded, and the cells were 
resuspended in the small amount of DMEM remaining in the tube. 
The cells were chemically fused by adding 1 ml of PEG to the 
dispersed cells over a 10 sec period and incubating the cells 
for 1.5 min in a 37 C water bath. One ml of DMEM was then 
added to the cells over a 10 sec period followed by a 30 sec 
incubation period. Finally, 10 ml of DMEM was added to the 
cells over a 30 sec period. This was followed by a final 
incubation of 5 min at 37 C, The cells were then pelleted at 
250xg for 8 min, and the supernatant was discarded. The cells 
were resuspended in HAT medium to a final concentration of 
5 X 10^ SP2/0 cells per ml. For fusions where SI hybridomas 
were used as the immunogen, two drops of the cell suspension 
was dispensed into each well of a 96 well tissue culture plate 
(Fisher; #08-757-155). For fusions where rabbit SMV Abs were 
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used as the immunogen, 1.0 ml of the cell suspension was 
dispensed into each well of a 24 well tissue culture plate 
(Fisher; #08-757-156). The cells were then incubated at 37 C. 
After 3 to 4 days, the depleted HAT medium was aspirated 
from the cells and replaced with fresh medium. Cells were fed 
either every 3 to 4 days or when the medium became slightly 
acidic, as indicated by a yellow color. The hybridomas were 
sequentially fed twice with HAT, twice with HT, and finally 
with DMEM-R. 
To detect specific antibody-producing hybridomas, an 
indirect ELISA was performed on yellow, spent hybridoma 
medium. Hybridomas were subsequently cloned in either HT or 
DMEM-R. 
Cel 1 freezing protocol 
Established cells which had grown to a density of 1 to 
3 X 10^ cells per 10 ml of medium in a Corning T flask 
(Fisher; #10-126-30) were centrifuged, and the cell pellet was 
resuspended in 1 ml of cell freezing medium. Approximately 
300 jul aliquots of the cell suspension were dispensed into 1.2 
ml Nunc cryotubes (Vangard International, Neptune, NJ; 
#366556), stacked in styrofoam containers and then frozen at 
-100 C in a Queue Cryostar freezer (Lab Research Products, 
Lincoln, NE). Cells were either left in the freezer or 
transferred to liquid nitrogen for storage. 
To freeze established cells which had grown to confluency 
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on the bottoms of the wells of 96 or 24 well tissue culture 
plates, growth medium was aspirated and replaced with cell 
freezing medium. The tissue culture plates were then placed 
into styrofoam containers and frozen at -100 C. 
Frozen cells were allowed to thaw at room temperature, 
after which the cell freezing medium was aspirated. Cells 
frozen in Nunc tubes were transferred to sterile 15 ml Corning 
centrifuge tubes (Fisher; #05-538-530) containing 10 ml of 
DMEM-R or HT and pelleted by centrifugation. The supernatant 
was discarded and the cells were resuspended in 5 to 10 ml of 
DMEM-R or HT, transferred to 70 ml tissue culture flasks and 
incubated. 
For cells frozen in tissue culture plates, the freezing 
medium was aspirated, and the cells were fed with DMEM-R or 
HT and incubated. 
Cell cloning protocol 
To obtain a homogeneous population of Ab-secreting cells 
which had arisen from a single cell, hybridomas were cloned 
according to the following procedure. Hybridomas which had 
grown to confluency on the bottom of a well of a tissue 
culture plate were resuspended using a sterile cotton-plugged 
Pasteur pipette equipped with a rubber bulb. Three drops 
(approximately 150 jjI) of the cell suspension were trans­
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ferred to a 15 ml centrifuge tube containing 15 ml of DMEM-R 
or HT. The contents of the tube were mixed and dispensed in 2 
drop aliquots (approximately 100 ;j1) into the wells of 96 well 
tissue culture plates. After 3 to 4 days, the plates were 
scanned at 40X with an inverted phase microscope to identify 
wells which contained single colonies. An indirect enzyme 
linked immunosorbent assay (ELISA) was used to detect those 
wells producing specific Ab. Although it was assumed that a 
single colony stemmed from a single cell, the cloning 
procedure was repeated 3 to 4 times to insure the monoclonal 
nature of each cell line. 
Enzyme Linked Immunosorbent Assays 
Basic ELISA protocol 
Anti-idiotype hybridomas generated against SI or SMV Abs 
were identified and characterized using variations of a basic 
ELISA protocol. Ninety-six well polyvinyl chloride plates 
(12 columns by 8 rows of wells) (Fisher; #14-245-142) were 
used as the solid phase in the assays to bind or retain 
appropriate immunological reagents. 
Although solid phase ELISAs are convenient and sensitive, 
they can nevertheless present some problems. Some hybridoma 
Abs which react with reagents bound to a solid phase may not 
react with the same reagents in solution (118). In addition, 
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some anti-idiotype McAbs have lower affinity for the idiotypic 
McAb than the idiotype Ab has for the antigen (19). There­
fore, competition assays involving the idiotype Ab, anti­
idiotype Ab and antigen may not be straightforward. Some IgM 
Abs may also bind to the solid phase plastic with or without 
recognizing the reagents attached to the plastic. 
To circumvent these potential problems, modifications of 
a basic ELISA protocol were developed for the purpose of 
describing the characteristics of the Abs generated in this 
study. In the basic protocol, wells of polyvinyl plates were 
coated with 50 ^ 1 of an appropriate reagent diluted in O.IM 
PBS, pH 7.1. Plates were incubated either for 1 hr at room 
temperature (RT) or overnight at 4 C. All incubation steps 
were carried out in a humidified box. After coating, the 
wells were emptied and filled with wash buffer. The plates 
were washed 10 times after this and every subsequent step. 
Wash buffer (WB) consisted of a 1:10 dilution of a lOX, pH 7.4 
WB concentrate. The concentrate was prepared by titrating 
solution A against solution B to pH 7.4. Solution A contained 
28.4 g of NagHPO^, 8.5 g of NaCl, 5 ml of Tween 20 (Sigma; 
#1379), 0.125 g of Thimerosal (Sigma; #T5125), and water to 1 
liter. In lieu of Na^HPO^, solution B contained 24 g of 
NaHgPO^. After washing, wells were filled with WB containing 
1 % bovine serum albumin (BSA) (Sigma; #4503) and incubated for 
1 hr at RT. Wells were then emptied, after which 50 jul of a 
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second immunoreagent (ascites fluid, protein A purified Ab, 
biotinylated Ab, virus or hybridoma medium) was added to each 
well. These immunoreagents were diluted in WB containing 1% 
BSA (1BWB) with the exception of hybridoma medium which was 
diluted 1:1 in WB containing 2% BSA (2BWB). Plates were 
incubated for 1 hr at RT with virus or for 3.5 hr at RT with 
all other immunoreactants. After washing, 50 ;j1 of either 
alkaline phosphatase conjugated goat anti-animal Ab diluted 
1:1000 in IBWB or alkaline phosphatase conjugated avidin 
(Sigma; #A2527) diluted to 0.16 jug per ml of IBWB was added to 
each well. Goat anti-animal Abs were derived against mouse 
IgG (Sigma; #A5153), mouse IgM (Sigma; #A774), mouse IgA 
(Sigma; #A7659), rabbit IgG (Sigma; #A8025) and rat IgG 
(Sigma; #A9654). After a 1 hr incubation at RT, the plates 
were washed, and 50 jul of para-nitrophenyl phosphate substrate 
(Sigma; #104-0) was dispensed into each well. The substrate 
solution was prepared by mixing 1.0 g of para-nitrophenyl 
phosphate, 40 ml of diethanolami ne and 210 ml of water and 
adjusting the pH to 9.8 with concentrated HCl. The substrate 
solution was stored at 4 C. Plates were incubated with 
substrate at 37 C for color development. The optical density 
of each well was measured in a Dynatech Mini reader II 
(Dynatech Laboratories Inc., Alexandria, VA: #011-930-0500) 
operating at 405 nm. 
On many occasions, ELI SA plates which had been treated. 
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washed and tapped dry, were wrapped in kitchen plastic wrap 
and stored at 4 C. After storage, these plates were washed 
once with WB prior to' use. 
The following procedures use modifications of this basic 
ELISA protocol. 
Mouse serum screen for anti-Sl idiotope Ab production 
An ELISA was used to screen mice for anti-Sl idiotope Ab 
production. Sera from mice injected with SI were diluted 1:10 
with PBS. Wells of a polyvinyl plate were coated with the 
diluted sera (50 jul per well) for 1 hr at 37 C, washed and 
blocked. Fifty ^ 1 of biotinylated 51 (2 pg per ml of IBWB) 
was added to each well. The plates were incubated for 1 hr at 
RT and then washed prior to the addition of avidin alkaline 
phosphatase. The remainder of the assay was completed 
according to the basic ELISA protocol. 
Mouse serum check for anti-idiotope Ab production to SMV Ab 
Wells of a polyvinyl plate were either left uncoated or 
were coated with 62.5 ng of TRSV Ab or SMV Ab for 1 hr at RT. 
The plate was then washed and blocked prior to the addition of 
mouse sera (approximately 50 jjl per well). After a 2 hr 
incubation at RT, the plate was washed, and goat anti-mouse 
IgG alkaline phosphatase was added. The remainder of the 
assay was completed according to the basic ELISA protocol. 
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Optimization of idiotype Ab concentration for ELISA 
Goat anti-mouse conjugates were used to detect hybri-
doma anti-idiotype Abs which had reacted with the bound 
idiotype Abs. These conjugates also reacted with the bound 
idiotype Abs themselves if the concentration of the coating 
idiotype Ab was sufficiently high. To avoid this nonspecific 
reaction, it was necessary to determine the optimal concen­
tration of idiotype Ab for coating ELISA plates. 
Fifty 1 of PBS was added to each well of a polyvinyl 
plate. Fifty jul of SI or SMV Ab, diluted to 40 jug per ml of 
PBS, was then added to the first row of wells. A Titertek 
multichannel pipet (Flow Laboratories, McLean, VA; #77-859-
001) was used to mix the contents of the first row of wells 
and to subsequently transfer 50 jul volumes of fluid to the 
second row of wells. This process was repeated through row 7 
with pipet tips being changed prior to each dilution step. No 
Ab was added to the control wells in row 8. The plates were 
incubated for 1 hr at RT, then washed. The appropriate goat 
anti-mouse conjugate was then added and the plates were again 
incubated. After washing, substrate was added, and the plates 
were read after a 2 hr incubation. 
The optimum idiotype coating concentration was determined 
by selecting the highest concentration of idiotype Ab which 
gave an O.D. reading of 0.05 or less. For SI, the optimum 
coating concentration was 0.25 to 0.50 jug per ml (12.5 to 25 
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ng per 50 jjl aliquot). For SMV Ab, 1 jug per ml (50 ng per 50 
jjl aliquot) proved optimal. 
Identification of hybridoma anti-idiotope Abs b.v indirect 
ELISA 
Polyvinyl plates were divided into 3 groups, each of 
which consisted of 4 columns of wells. In the SI syngeneic 
system, each group consisted of 2 columns of wells coated with 
SI (25 ng per well), 1 column of wells coated with a control 
Ab of the same isotype (MAGI I, 25 ng per well), and 1 column 
of uncoated wells. The plates were incubated, washed and 
blocked according to the basic ELISA protocol. In each of the 
3 groups, 1 column of SI coated wells then received 500 ng of 
SMV diluted in 1BWB. The remaining columns of wells in each 
group received no additional reagents. The plates were 
incubated for 1 hr at RT, washed, and either stored at 4 C or 
used immediately. 
Hybridoma medium to be assayed for anti-idiotype Ab 
production was first diluted 1:1 with 2BWB. It was then 
transferred in 50 iil volumes to each of 4 wells containing 
either blocking buffer, SI, SI and SMV, or MAGI I. As a 
control, SP2/0 medium was substituted for hybridoma medium. 
The remainder of the assay was completed according to the 
basic ELISA protocol. 
Hybridomas yielding O.D. readings which were higher for 
wells containing SI than for those containing blocking buffer. 
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SI and SMV, or MAGI I were identified and cloned. 
The indirect ELISA protocol was also used to identify 
anti-idiotype hybridoma Ab producing cells in the SMV Ab 
xenogeneic system. However, SMV Ab (50 ng per well) and TRSV 
Ab (50 ng per well) were substituted for SI and MAGII, 
respecti vely. 
In addition, to determine if Abs to SMV were produced by 
mice injected with SMV Ab, 2 columns of wells on each plate 
were coated with SMV (500 ng per well) and blocked. No rabbit 
Ab was added to these wells. 
Hybridomas which reacted more strongly with SMV Ab coated 
wells than with those containing blocking buffer, SMV Ab and 
SMV, or TRSV Ab were also identified and cloned. 
The anti-idiotope Abs AB9, 1, la, 2 and 3, were identi­
fied and cloned in the SI syngeneic system. The anti-idiotope 
Abs A3A, A4D, B3A and C6A, were identified in the SMV Ab 
xenogeneic system, but only the B3A hybridoma was cloned 
successfully. 
Optimization of anti-idiotope ascites dilutions for ELISAs 
Anti-idiotope ascites fluid which contained a high 
concentration of Ab was used in competition assays involving 
virus and idiotype Abs. 
All of the SI anti-idiotype Abs generated in this study 
were IgM Abs. At high concentrations, these IgM Abs bound 
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nonspecifically to the BSA blocked polyvinyl plates. When 
goat anti-mouse IgM alkaline phophatase was used as the 
conjugate, these IgM Abs produced unacceptably high back­
ground O.D. responses. 
The following assay was therefore developed to detei— 
mine the optimum ascites dilution used in competition ELI SAs. 
Fifty Ail of 31 diluted to 4 ^ g per ml was added to the first 
column of wells. Two-fold dilutions were then carried out 
through row 11. No SI was added to row 12. The plates were 
incubated for 1 hr at RT, washed and blocked. After a second 
wash, the plates were emptied, and 50 jul of IBWB was added to 
each of the 96 wells to serve as a diluent. Fifty 1 of 
either AB9, 1, la, 2 or 3 ascites, diluted 1:250 in IBWB, was 
added to the first row of wells, and further diluted two fold 
through row 7. No ascites fluid was added to row 8. Goat 
anti-mouse IgM alkaline phosphatase was used as the conjugate. 
The remainder of the assay was carried out according to the 
basic ELISA protocol. 
A P/N (positive to negative) ratio was determined for 
each anti-idiotope Ab. This was accomplished by dividing the 
O.D. reading when all reactants were present by the O.D. 
reading when all reactants except 31 were present. The 
dilution of ascites which gave the highest P/N ratio was then 
used in compet i t ion assays where goat anti-mouse IgM alkaline 
phosphatase was used as the conjugate. 
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Competition ELISAs 
A series of competition ELISAs were used to determine if 
anti-idiotope Abs mimicked SMV and could compete with the 
virus for the idiotope Ab. 
In all competition assays, concentrations of two of the 
three reactants (SMV, idiotope Ab and anti-idiotope Ab) were 
held constant while the concentration of the third reactant 
was varied. Competition between the reactants was reflected 
by changes in O.D. readings which corresponded to changes in 
the concentrations of the third reactant. For each dilution 
of reactant 3, competition was generally expressed by the 
equation 
% O.D. inhibition - A - B x 100 
A 
where 
A = O.D. reading obtained when all but the third 
reactant was present and 
B = O.D. reading obtained when all three reactants 
were present. 
Competition assay between SMV and syngeneic anti-idiotope Ab 
in ascites for bound SI 
Polyvinyl plate wells in columns 1 through 6 were each 
coated with 25 ng of SI. Control wells in columns 7 through 
12 remained uncoated or were coated with 25 ng of MAGI I. 
Plates were blocked, washed and tapped dry. Optimum dilutions 
4 3  
of each anti-idiotope Ab in ascites fluid were prepared in 
IBWB. Fifty jjl of each anti-idiotype Ab preparation was added 
to each well in an SI coated column of wells and to a control 
column of wells. Each Ab preparation was also used to dilute 
SMV. Fifty ,ul of SMV, diluted to 200 ng, was added to each of 
the first row wells which already contained the corresponding 
Ab preparation. Two fold dilutions were carried out through 
row 7. Plates were incubated for 3.5 hr at RT and washed. 
Goat anti-mouse IgM conjugate was then added to all wells to 
detect IgM anti-idiotope Ab which had bound to SI. The 
remainder of the assay was completed according to the basic 
ELISA protocol. 
For each anti-idiotope Ab and at each SMV dilution, 
competition between SMV and anti-idiotope Ab for bound SI was 
expressed as % O.D. inhibition according to the equation 
% O.D. inhibition = A - B x 100 
A 
where 
A = O.D. of all reactants except SMV and 
B = O.D. of all reactants. 
Competition between bioti n.vlated SI and SMV for bound 
syngeneic anti-idiotope Ab 
The IgM anti-SI idiotope Abs in ascites were found to 
bind nonspecifically to polyvinyl plates. Optimum dilutions 
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of each ascites anti-idiotope were made in PBS. Each diluted 
anti-idiotope Ab was used to coat a column of wells in the 
plate. A column of uncoated wells served as a control. The 
plates were blocked, washed and tapped dry. Biotinylated 51 
diluted to 0.5 jug per ml of 1BWB was added to each well. The 
same reagent was also used to dilute SMV. Fifty jul of SMV 
(20 ,ug per ml of biotinylated SI in IBWB) was added to each 
well in row 1. Two fold dilutions were then made through row 
7. Wells in row 8 received no SMV. Plates were incubated for 
3.5 hr at RT and washed prior to the addition of the avidin 
alkaline phosphatase conjugate. The remainder of the assay 
was completed according to the basic ELISA protocol. 
For each anti-idiotope Ab and at each SMV dilution, 
competition between SMV and SI for bound anti-idiotope Ab was 
expressed as % O.D. inhibition according to the equation 
7o O.D. inhibition = A - B x 100 
A 
where 
A = O.D. of all reactants except SMV and 
B = O.D. of all reactants. 
Competition between SMV and xenogeneic anti-idiotope Abs for 
bound SMV Abs 
Each well in columns 1 through 5 on polyvinyl plates was 
coated with 50 ng of SMV Ab. Control wells in columns 7 
through 12 were either coated with 50 ng of  TRSV Ab or left 
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uncoated. The plates were washed, blocked and tapped dry. 
BWB was added to each well. Fifty jul of SMV diluted to 40 ai g 
per ml in 1BWB was added to each of the wells in the first row 
and two fold dilutions were carried out through row 7. No SMV 
was added to control wells in row 8. The plates were 
incubated for 1 hr at RT, washed and tapped dry. Medium from 
each anti-idiotope Ab producing hybridoma was diluted 1:2 with 
2BWB, and 50 ^ 1 of the diluted medium was added to a column of 
control wells and to a column of SMV Ab coated wells. The 
plates were incubated for 1 hr at RT. Goat anti-mouse IgG was 
then added to all wells and the basic ELISA protocol was 
followed for the remainder of the assay. 
For each anti-idiotope Ab and at each SMV dilution, 
competition between SMV and anti-idiotope Ab for bound SMV Ab 
was expressed as % O.D. inhibition according to the equation 
% O.D. inhibition = A - B x 100 
A 
where 
A = O.D. of all reactants except SMV and 
B = O.D. of all reactants. 
Reactivity of anti-idiotope Abs with monoclonal and 
polyclonal Abs and SMV 
To determine if anti-idiotope Abs to SI recognized 
intraspecies and interspecies CRIs on other Ab molecules or 
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recognized SMV, the following assay was performed. 
Wells in polyvinyl plates were coated either with SI 
(12.5 ng), NDV3H4 (12.5 ng), SMV Ab (50 ng), TRSV Ab (50 ng), 
or SMV (500 ng) diluted in PBS. A control set of wells was 
left uncoated. Plates were blocked, washed and tapped dry. 
Anti-idiotope ascites fluid was diluted either 1:100 (anti-
idiotope AB9), 1:2000 (anti-idiotope 2) or 1:4000 (anti-
idiotope 1, la, 3) with IBWB. Each of the diluted anti-
idiotope Abs was then added to a set of wells coated with one 
of the reagents listed in the first step. The plates were 
incubated for 3 to 5 hr at RT, washed and tapped dry. Goat 
anti-mouse IgM alkaline phosphatase was then added. The 
remainder of the assay was completed according to the basic 
ELISA protocol. 
Reactivity of anti-idiotope Abs with SMV and other viruses 
In the previous assay, anti-idiotope Abs to SI reacted 
with SMV. To determine if these same Abs reacted with other 
viruses, the following assay was performed. 
Polyvinyl plates were coated with 100 ng of either SMV, 
MDMV-A, BYDV-RPV, LMV, NOV or TMV diluted in PBS. A control 
set of wells was not coated with virus. The plates were 
locked, washed and tapped dry. Anti-idiotope ascites fluid 
was diluted either 1:100 (anti-idiotope AB9), 1:2000 (anti-
idiotope 1, 2, 3) or 1:4000 (anti-idiotope la) with IBWB. 
Each of the diluted anti-idiotope Abs was then added to a set 
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of wells coated individually with one of the reagents listed 
in the first step. The plates were incubated for 4 hr at RT, 
washed and tapped dry. Goat anti-mouse IgM alkaline 
phosphatase was then added, and the basic ELISA protocol was 
followed for the remainder of the assay. 
Reactivity of anti-Sl idiotope Abs with SMV 
In previous assays, some of the anti-idiotope Abs to SI 
appeared to recognize SMV. To determine if this recognition 
could be specifically affected by the concentration of SMV, 
the following assay was performed. 
Fifty ju 1 of PBS was added to each well of a polyvinyl 
plate. Fifty ju 1 of SMV (200 ug per ml of PBS) was added to 
each of the wells in the first column. Two-fold serial 
dilutions were then carried out through row 11. Control wells 
in row 12 were not coated with SMV. The plates were incubated 
for 1 hr at RT, washed, blocked, and rewashed. Anti-idiotope 
ascites fluid was diluted 1 : 1000 with 1BWB. Fifty jul of each 
of the diluted anti-idiotope Ab preparations was added indi­
vidually (50 jjl per well) to a row of wells coated with 
decreasing concentrations of SMV. In a similar fashion, and 
as a positive control, SMV Ab (1 jug per ml of 1BWB) or TRSV 
Ab (1 jjg per ml of 1BWB) was also added to wells coated with 
SMV. The plates were incubated for 3.5 hr at RT, washed and 
tapped dry. Alkaline phosphatase conjugated goat anti-mouse 
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IgM or anti-rabbit IgG was added to the appropriate wells. 
The basic ELISA protocol was then followed for the remainder 
of the assay. 
Competition between SMV and SMV Ab for bound la anti-idiotope 
Abs 
From previous assays, la apparently recognized SMV and 
SMV Abs. To determine if the same binding site on la was used 
to recognize both SMV and SMV Ab, the following competition 
assay was performed. 
Polyvinyl plates were coated with anti-idiotope la 
ascites diluted 1:1000 with PBS. Plates were washed, blocked 
and tapped dry. Fifty jul of SMV Ab (10 ^ g per ml of 1BWB) was 
added to each of 8 wells. As a control, 50 ^ 1 of IBWB was 
added to a second set of wells. Fifty jul of SMV (80 ^ g per 
ml) diluted with either SMV Ab (10 jug per ml of IBWB) or IBWB 
was added to the first well of each set containing the 
corresponding diluent. Two-fold dilutions were made through 
well 7. No virus was added to well 8. The plates were 
incubated for 3.5 hr at RT, washed and tapped dry. Goat anti-
rabbit IgG alkaline phosphatase was then added and the basic 
ELISA protocol was followed for the remainder of the assay. 
At each SMV dilution, competition between SMV and rabbit 
anti-SMV Ab for bound la anti-idiotope Ab was expressed as % 
O.D. inhibition according to the equation 
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% O.D. inhibition = A - B 
?r~ 
where 
A = O.D, of all reactants except SMV and 
B = O.D. of all reactants. 
Competition between SI and SMV Abs for bound la anti-idiotope 
Abs 
The fact that Si and rabbit anti-SMV Abs were both 
recognized by anti-idiotope Ab la suggested that these two 
entities might share a CRI and thus compete with each other. 
Such interspecies CRTs have been described previously (13, 59, 
78, 102, 117). To determine if such a CRI were present, a 
protocol similar to that used in the competition assay 
involving SMV, rabbit anti-SMV Ab and la was followed. The 
only modification involved substitution of SI for SMV. 
At each SI dilution, competition between SI and rabbit 
anti-SMV Ab for bound la was expressed as % O.D. inhibition 
according to the equation 
% O.D. inhibition = 0.0. with SI x 100 
O.D. without SI 
Optimization of anti-idiotope la and A4D ascites concentration 
for detection of SMV Abs 
The following protocol was developed to determine the 
optimum concentration for coating plates with ascites fluid 
containing anti-idiotope Abs which would detect rabbit anti-
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SMV Ab. 
Fifty jul of PBS was added to wells in rows 2 through 12 
of a polyvinyl plate. Fifty jul of la ascites (diluted 1:250 
in PBS) or A4D ascites (undiluted) was added to each well in 
row 1. The ascites was serially diluted two-fold through row 
11. The plates were incubated, washed, blocked and tapped 
dry. Fifty jul of 1BWB was added to each well. SMV Ab and 
TRSV Ab (control) were diluted to lOjjg per ml in IBWB. Fifty 
oil of either reactant was added to each well in row 1 and 
serially diluted two-fold through row 7. Row 8 received no 
rabbit Ab. The plates were incubated for 3.5 hr at RT, washed 
and tapped dry. Following the addition of goat anti-rabbit 
alkaline phosphatase to each well, the assay was completed 
according to the basic ELISA protocol. 
The optimum ascites coating concentration was defined as 
that concentration which gave the highest positive (all 
reactants present) to negative (all reactants except SMV Ab 
present) ratio. 
Reactivity of IgG Abs from rats injected with either anti-
idiotope Ab la or 3 
The extent of the immune response elicited in rats by 
anti-idiotope Abs la and 3 was determined according to the 
following assay. Each V-shaped well of a Dynatech polyvinyl 
plate (Fisher #14-245-74) was coated with either SI (100 ng), 
NDV4F11 (100 ng), SMV (400 ng), SMV Ab (500 ng) or ascites 
AB9, 1, la, 2 or 3 diluted 1:500. All reagents were diluted 
in PBS. A set of uncoated wells served as the control. 
Plates were incubated for 1 hr at RT, washed, blocked, washed 
a second time and tapped dry. Ten jul of rat serum from each 
bleeding was added to a set of wells coated with one of the 
reagents listed above. Positive controls consisted of sets of 
coated wells to which 50 jul volumes of biotinylated SI (2 jjg 
per ml of IBWB) were added. The plates were incubated 
overnight at 4C. After washing, 50 jul of avidin alkaline 
phosphatase was added to each of the positive control wells 
and 50 jul of goat anti-rat IgG alkaline phosphatase was added 
to all of the remaining wells. The remainder of the assay was 
completed according to the basic ELISA protocol. 
Reactivity of biotinylated SI with IqG2a kappa McAbs 
When results of the assay used to determine the immune 
response of rats to anti-idiotope Abs la and 3 were analyzed, 
the Abs produced by some of the rats unexpectedly reacted with 
SI. Biotinylated SI, used as the positive control in the same 
assay, also reacted with SI. To determine the extent with 
which biotinylated SI reacted with SI and other IgG2a kappa 
McAbs, the following assay was developed. 
Fifty jjl of PBS was added to each well in rows 1 through 
8 of a polyvinyl plate. Fifty jul of either SI, MAGII, NDV4F11 
or NDV3H4, initially diluted to 50 jjg per ml in PBS, was added 
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to separate wells in row 1 and serially diluted two-fold 
through row 7. Wells coated with two-fold serial dilutions of 
SMV served as positive controls. Wells in row 8 remained 
uncoated. After a 1 hr incubation at RT, the plates were 
washed, blocked, rewashed and tapped dry. Each well then 
received 50 1 of biotinylated SI (2 ojg per ml of 1BWB). The 
plates were incubated 3.5 hr at RT, washed and tapped dry. 
Fifty jLil of avidin alkaline phosphatase was added to each 
well, and the remainder of the assay was completed according 
to the basic ELISA protocol. 
Competition between biotinylated SI and SMV for bound SI 
Results from the previous assay suggested that biotin­
ylated SI recognized SI bound to polyvinyl plates. A 
competition assay was therefore developed to determine if 
biotinylated SI and SMV recognized the same site orrSl. 
The wells of polyvinyl plates were coated with 50 jjl of 
SI diluted to 10 jug per ml with PBS. The plates were 
incubated for 1 hr at RT, washed and blocked according to the 
basic ELISA protocol. Fifty xil of biotinylated SI diluted to 
2 ijg per ml of 1BWB was added to each well. Fifty 1 of SMV 
diluted to 200 j jg per ml in IBWB was added to the first four 
wells in column 1. The second four wells in column 1 received 
TMV diluted to 200 j jg per ml in IBWB and served as a control. 
The viruses were serially diluted two-fold through column 11. 
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Wells in column 12 received no virus. The plate was incubated 
for 3.5 hr at RT, washed and tapped dry. Fifty jul of avidin-
alkaline phosphatase diluted in 18WB was added to each well, 
and the remainder of the assay was completed according to the 
basic ELISA protocol. 
At each SMV dilution, competition between SMV and bio-
tinylated SI for bound SI was expressed as % O.D. inhibition 
according to the equation 
% O.D. inhibition = A - B x 100 
A 
where 
A = O.D. of all reactants except virus and 
B = O.D. of all reactants. 
Immunoglobulin class and subclass determination 
An attempt was made to determine the subclass and light 
chain identity of the anti-idiotope Abs generated in this 
study. For this purpose, the MonoAb-ID EIA kit (Zymed 
Laboratories, Inc., San Francisco, CA; #90-6550) was used. It 
contained the appropriate Immunochemical reagents and several 
protocols which could be followed for isotype determination. 
For this assay, the protocol labelled "Captured EIA for 
Isotype Determination" was used. Prior to assay, anti-
idiotope samples were diluted either 1:10 (for hybridoma 
medium) or 1:1000 (ascites fluid) with 1BWB. Controls 
consisted of SP2/0 medium assayed in a similar fashion. 
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Competition Assay Between SMV and Anti-idiotype 
Abs on Detached Leaves 
Milbrath and Soong's semi-quantitative local lesion assay 
for detection of SMV (77) was used to determine if anti-
idiotope Abs could mimic SMV and therefore inhibit SMV local 
lesion formation on detached Phaseolus vulgaris L. CV. Top 
crop leaves. 
Top crop beans with fully expanded primary leaves were 
incubated for 12 to 18 hr at RT in the dark. Each leaf was 
then dusted with 600 mesh carborundum, removed from the plant 
and placed in a petri dish containing moist filter paper. 
Phosphate buffer was used to dilute all reagents applied 
to the leaves. It was prepared by titrating 0.05M NaH^ PO^ 
against 0.05M Na^HPO^ until a pH of 7.0 was attained. 
Opposite halves of leaves were mechanically inoculated 
with 25 jjI  o f  buffer (control) and either SP2/0 medium, 
anti-idiotope Ab hybridoma medium or ascites fluid diluted 1:2 
with buffer. The leaves were returned to the dark for 3.5 hr 
at RT. 
An SMV-infected soybean (Glycine max CV, Williams) leaf, 
approximately one centimeter square, was homogenized in 0.5 ml 
of buffer. Twenty-five jul of the liquid extract was mechani­
cally inoculated onto each side of each leaf. 
The petri dishes containing the inoculated leaves were 
sealed with parafilm and placed in a 30 C incubator equipped 
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with a 25 watt incandescent light source. After 3 to 5 days, 
SMV local lesions, which appeared as brown necrotic spots on 
the infected leaf tissue, were counted. 
Inhibition of SMV infectivity in plants by anti-idiotype 
Abs was expressed as Z reduction in local lesion number 
according to the equation 
% reduction in local lesion number = 100 - (A/B x 100) 
where 
A = number of local lesions on treated side of leaf and 
B = number of local lesions on control side of leaf. 
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RESULTS 
Immunization of Mice with the 31 Idiotype Ab 
Five mice were injected with glutaraldehyde fixed 51 
hybridomas or protein A purified 31 for the purpose of 
stimulating anti-idiotype Ab production. When assayed by 
ELI SA, the serum of only one of these mice reacted with 
biotinylated 31. Plates coated with the five mouse serum 
samples and reacted with biotinylated 31 yielded O.D. readings 
of 0.02, 0.02, 0.04, 0.07 and 0.18 after an overnight 
incubation with substrate. The spleen from the mouse whose 
serum gave the highest O.D. reading was later used to generate 
the anti-Si idiotype Abs in this study. 
Immunization of Mice with Rabbit Abs 
Four mice were injected initially with cyclophosphamide 
and TRSV Ab in an attempt to suppress the immune response to 
common rabbit Ab epitopes. A second injection consisting of 
SMV Ab was administered at a later date. Three of the four 
mice survived and produced IgG Abs to both SMV Ab and TRSV 
Ab. Using the basic ELISA protocol, O.D. readings obtained 
for the reaction between mouse serum IgG and SMV Ab or TRSV Ab 
(SMV Ab/TRSV Ab) were 0.50/0.71, 0.42/0.55 and 0.36/0.45 
respectively for the three mice. The spleen from the last 
mouse was subsequently used to generate the hybridoma Abs in 
this study. 
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Success Rates for Cell Fusion, Freezing and Thawing 
Hybridomas were visible approximately three to four days 
following cell fusion. Within two weeks, nearly 90% of the 
wells used for the anti-Si idiotype fusion and 98% of those 
used for the anti-SMV Ab idiotype fusion contained one or more 
cell colonies. 
One hundred percent of all cells frozen in vials were 
recovered after six or more months of storage at -100 C. 
Eighty four percent of the wells containing cells frozen in 96 
well tissue culture plates and nearly 100% of those containing 
cells frozen in 24 well plates were recovered after three or 
more months of storage at -100 C. When the DMSO-freezing 
medium was not removed within 5 to 10 min after the last well 
had thawed, the survival rate of the cells appeared to drop 
appreci ably. 
Optimization of the Basic ELISA Protocol 
During the development of the basic ELISA protocol, 
several factors were found to significantly influence the 
reproducibility and sensitivity of the assays. These included 
the physical and chemical nature of the ELISA plates, the 
makeup of the blocking and diluting buffers, and incubation 
conditions. 
Several types of microti ter plates were initially 
screened for use in ELI SAs. The results obtained with 
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polyvinyl plates were more reproducible than those obtained 
with more expensive plates such as Dynatech Immulon I and II 
(Fisher; #14-245-78; #14-245-61) and Nunc (Nunc; #439454). 
Optimal incubation temperatures for all ELISA steps, 
other than substrate addition, were RT or 4 C. At 37 C, 
excessive variations in O.D. readings for replicate wells were 
noted. 
To circumvent the well-known "edge effect" where outer 
wells of ELISA plates exhibit excessively high O.D. readings 
irrespective of pertinent immunological reactions, plates were 
incubated in sealed moist chambers. 
Microti ter plates were washed and blocked with PBS-Tween 
containing BSA (BWB). Other blocking reagents, including 
1 % BSA in PBS, 1 % horse serum in WB, 1 % calf serum in WB and 
1% fetal bovine serum in WB, reacted non-specifical1y with the 
Sigma goat anti-mouse alkaline phosphatase conjugate and gave 
unacceptably high background O.D. responses. Results obtained 
when WB alone or Blotto were tested as potential blocking 
reagents were similar to those for BWB. 
PBS-Tween containing BSA (BWB) was also used to dilute 
all reagents used in the assay, with the exception of 
substrate. When BWB was used as a diluent, non-specific 
reactions between some of the 1mmunoreagents and the 1BWB 
blocked plates were minimized. 
ELISA proved superior to a dot blot screening assay for 
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detection of anti-Si idiotype Ab producing hybridomas (11). 
Biotinylated SI was used to qualitatively assay for any anti-
Si idiotype Ab present in hybridoma medium dotted onto nitro­
cellulose strips. This method was later abandoned, however, 
in favor of the ELISA, since it was difficult to visually 
discriminate between the responses provided by weakly posi­
tive hybridomas and negative controls. 
Identification of Anti-Sl Idiotope Hybridomas 
by Indirect ELISA 
Anti-Sl idiotype hybridomas were difficult to identify 
since differences in O.D. readings between the anti-idiotype 
antibodies and SI or the controls (SI plus SMV, MAGII or 
blocking buffer) were small. 
The fusion in which g 1utaraldehyde-fixed SI hybridomas 
were used as the immunogen yielded approximately 300 tissue 
culture wells containing hybridomas. Of these, only 
hybridomas 1, la, 2 and 3 were selected for further study. 
The interactions between antibodies produced by these 
hybridomas and the reagents SI, SI plus SMV, MAGII and BWB 
listed in Table 1 were reproducible in two or more separate 
experiments. Although actual O.D. readings varied from 
experiment to experiment, those presented in Table 1 repre­
sent the typical, reproducible pattern observed. 
Hybridomas 1 and la were derived from the same parental 
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wells. After four cloning cycles, it became apparent that 
there were either two different hybridomas present or that 
somatic mutations had occurred within a single hybridoma. 
Table 1. Anti-Sl idiotope Ab interactions with SI or other 
Abs or with SI plus SMV 
a 
Coating Reagent Anti-idiotope Ab 
1 la 2 3 AB9 
MAG 11 0.26 0.20 0.20 1.78 0.18 
SI 0.57 0. 51 0.46 1.91 0.13 
SI + SMV 0.41 0.55 0.35 1.75 0.11 
NDV3H4 0.00 0.00 0.00 0.00 0.00 
NDV4F11 0.00 0.42 1.09 2.15 0.00 
SMV Ab 0.00 0.45 0.00 0.00 0.00 
TRSV Ab 0.00 0.00 0.00 0.00 0.00 
BYDV Ab 0.00 0.00 0.00 0.00 0.00 
BWB 0.13 0.13 0.06 1.45 0.10 
a 
O.D. readings. 
The hybridoma designated AB9 in Table 1 was derived from 
a fusion using spleen cells from a mouse primed with pristane 
and used to generate SI ascites fluid. Initially, AB9, which 
was never cloned, reacted with the reagents listed in Table 1, 
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giving O.D. readings similar to those produced by-anti-
idiotope 1. However, after AB9 cells were injected into 
pristane primed Balb/c mice to generate AB9 ascites fluid, the 
interactions between AB9 and these reagents (Table 1) changed 
to the extent that AB9 reacted more strongly with the controls 
(MAGI I or SI plus SMV) than with SI. 
Identification of Anti-SMV Ab Idiotope 
Hybridomas by Indirect ELISA 
Hybridomas generated from the fusion involving an SMV Ab 
primed mouse were assayed by ELISA for activity against either 
SMV Ab, SMV, SMV Ab plus SMV, TRSV Ab or blocking buffer. 
Hybridomas from six of the 96 tissue culture wells produced 
IgG Abs which reacted most strongly with SMV Ab containing 
wells. Designations for five of these six hybridomas are 
presented in Table 2 together with the reactions their Abs 
yielded with the reagents listed above. The results are from 
one of two or more reproducible assays performed. Hybridomas 
from well A6C produced Abs which exhibited their strongest 
reactivity with blocking buffer only. The reactivity of these 
Abs with SMV Ab was also greater than their reactivity with 
SMV, SMV Ab plus SMV or TRSV Ab. Therefore, they were 
excluded from further study. 
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Table 2. Hybridoma Ab interactions with SMV Ab, TRSV Ab, SMV 
or SMV Ab plus SMV 
Hybridoma Ab Coating reagent 
a 
TRSV Ab SMV Ab SMV Ab 
+ 
SMV 
SMV BWB 
A3A 0.25 0. 38 0.24 0.00 0.04 
A4D 
b 
A4Dasc 
0.07 
0.57 
0. 59 
0.64 
0.32 
0.71 
0.00 0.03 
0.36 
A6C 1.91 2.00 1.24 0.00 2.10 
B3A 0.24 0.39 0.19 0.02 0.02 
B3A4B 0.17 0.20 0.16 - 0.00 
B3A5E 0.14 0.17 0.13 - 0.00 
B3A7F 0.00 0.00 0.00 - 0.00 
B3C 0.92 1.05 0.62 0.89 0. 72 
C6A 0.46 0.91 0. 54 0.00 0.03 
SP2/0 0.05 0.05 0.04 - 0.04 
a 
O.D. readings. 
b 
A4Dasc is the A4D hybridoma Ab generated in ascites 
rather than in tissue culture medium. 
When the hybridomas were first assayed, approximately 26% 
of the 96 tissue culture wells contained hybridomas that 
produced IgG or IgM Abs which showed stronger reactivity with 
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SMV than with control blocking buffer. Approximately 93% (89 
wells) of the wells produced IgG Abs which reacted more 
strongly with TRSV Ab than with any of the other reagents. Of 
these 89 wells, approximately 78% produced IgG Abs whose 
reactivity with SMV Ab exceeded that with SMV plus SMV Abs. 
Only hybridorna B3A was cloned successfully (Table 2). 
Clones B3A4B and B3A5E produced Abs which reacted more 
strongly with SMV Ab than with the other reagents. However, 
their reactivity was significantly weaker than that of the 
original B3A hybridorna. Clone B3A7F failed to produce Abs 
which recognized the various reagents. It was used later as a 
control in the SMV local lesion detached leaf assay. 
Antibodies produced by A4D in hybridorna medium reacted 
strongly with SMV Abs and weakly with the various other 
reagents (Table 2). However, when hybridoma A4D was used to 
generate ascites in pristane primed mice, Abs in the ascites 
showed their strongest reactivity with SMV plus SMV Ab. 
Syngeneic Anti-idiotope Ab Recognition of SI 
The anti-idiotope Abs 1, la, 2, 3 and AB9 reacted 
specifically with SI since a decrease in SI coating 
concentration corresponded to a decrease in O.D. readings 
(Figure 1). However, differences were noted among the anti-
idiotope Abs with respect to titer and affinity for SI. 
Extrapolation from Figure 1 yields the following order of 
Figure 1. ELISA results for anti-Sl idiotope Ab interactions 
with bound SI 
Each microti ter well in a set of wells was coated 
with a concentration of SI ranging from 0.001 to 
0.100 jug per well. Ascites fluid containing 
either anti-idiotope Ab 1, la, 2, 3 or AB9 was 
diluted 1:1000 and 50 u1 of diluted ascites was 
added to a set of SI coated wells. Results are 
expressed in terms of absorbancy readings obtained 
for each anti-idiotope Ab. 
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decreasing IgM Ab titer or SI affinity for the anti-idiotope 
Abs in ascites: 2, la, 3, AB9 and 1. 
Optimization of Anti-idiotope Ascites 
Dilution for Competition ELISAs 
For anti-idiotope Abs AB9 and 2, the highest P/N ratios 
were achieved when ascites fluid was diluted 1:500 and 1:4000 
respectively (Figure 2). Optimum ascites fluid dilutions 
could not be established for anti-idiotope Abs 1, la or 3 on 
the basis of P/N ratios. The affinity of these anti-idiotope 
Abs for SI was seemingly low as indicated by their low P/N 
ratios. Anti-idiotope Ab 3 did appear to have an optimum P/N 
ratio at a 1:16,000 dilution. However, this apparent P/N 
optimum ratio resulted from exceedingly low and mathematically 
insignificant O.D. readings. 
Competition Between SMV and Anti-Sl 
Idiotope Abs for Bound SI 
Increasing concentrations of SMV were found to inhibit 
the interaction between SI, with which microti ter ELISA wells 
were coated, and anti-Sl idiotope Abs (Figures 3 and 4). 
However, a linear relationship was not observed. The 
interactions between each of the anti-Sl idiotope Abs and 51 
were inhibited by SMV concentrations that were 0.25 pg per 
well or higher. At lower SMV concentrations, only anti-
Figure 2. Optimization of anti-Si idiotope Ab concentration 
for use in ELISA 
Each microti ter well was coated with 50 ng of SI 
McAb. Ascites fluid containing either anti-
idiotope Ab 1, la, 2, 3 or AB9 was diluted from 
1 : 500 to 1 :32,000. Fifty ;j1 of each dilution of 
ascites was added to a set of SI coated wells. 
Results are expressed in terms of P/N ratios for 
each anti-idiotope Ab in diluted ascites. 
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Figure 3. ELISA results for competition assays between SMV 
and anti-Si idiotope Abs for bound SI 
Each microti ter well was coated with 25 ng of SI 
McAb. Fifty jli 1 of either anti-Sl idiotope Ab la 
(1:4000 dilution of ascites) or anti-Sl idiotope 
Ab 3 (1:2000 dilution of ascites) was added to a 
set of SI coated wells. Immediately following the 
addition of anti-Sl idiotope Ab, SMV was added to 
each set of wells in concentrations ranging from 0 
to 1 .000 ojg per well. Results are expressed in 
terms of percent inhibition of the SI idiotope/ 
anti-idiotope interaction effected by competing 
SMV. 
7 0  
3 la 
% O.D. inhibition 
60: 
50 
40 
30 
20 
0 0.016 0.031 0.063 0.125 0.250 0.500 1.000 
SMV competing concentration in jjg/well 
Figure 4. ELISA results for competition assays between SMV 
and anti-Sl idiotope Abs for bound SI 
Each microti ter well was coated with 25 ng of SI 
McAb. Fifty ^1 of either anti-Sl idiotope Ab 1 
(1:2000 dilution of ascites), anti-Sl idiotope Ab 
2 (1:2000 dilution of ascites) or anti-Sl idiotope 
Ab AB9 (1:100 dilution of ascites) was added to a 
set of SI coated wells. Immediately following the 
addition of anti-Sl idiotope Ab, SMV was added to 
each set of wells in concentrations ranging from 0 
to 1000 ojg per well. Results are expressed in 
terms of percent inhibition of SI idiotope/anti-
idiotope interaction effected by competing SMV. 
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idiotope Abs 1, la and 3 were prevented from interacting with 
SI. 
The maximum percent inhibition observed for the various 
combinations of SI with anti-Sl idiotopes were as follows: 
58% for anti-idiotope Ab 3, 46% for anti-idiotope Ab 2, and 
42% for anti-idiotope Abs 1, la and AB9. Interestingly 
enough, anti-idiotope Abs 1 and la were inhibited maximally at 
an SMV concentration of 0.25 jug rather than 1.00 jug per well. 
The SMV inhibition curves for anti-idiotope Abs 1 and la were 
also similar. 
As a control, MAGII was used in lieu of SI in a similar 
SMV competition assay. However, the recognition of MAGII by 
the anti-Si idiotope Abs was quite weak, yielding very low 
O.D. readings (e.g. 0.06). When these readings were compared 
with the even lower O.D. readings (e.g. 0.00 to 0.05) obtained 
when SMV was included as a competitor, the mathematical 
calculations which were used to describe competition between 
SMV and anti-idiotope Ab for bound MAGII reflected a 
mathematical rather than a biological phenomenon. Therefore, 
these results are not presented in this study. 
Competition Between SMV and Biotinylated SI 
for Bound Anti-idiotope Ab 
Increasing concentrations of SMV only slightly inhibited 
the interactions between biotinylated SI and anti-idiotope Abs 
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2 and 3 (Figure 5). For anti-idiotope Ab la, an enhancement 
of the interaction between SI and la was observed as the SMV 
concentration was increased. The presence of SMV had no 
apparent influence on the interactions between SI and anti-
idiotope Abs 1 and AB9. Therefore, these results are not 
presented in this study. 
Reactivity of Anti-Si Idiotope Abs with 
Varying Concentrations of SMV 
In ELISAs, SMV Ab and anti-idiotope Ab la both appeared 
to react with SMV when the latter was used to coat microtiter 
wells. As the coating concentration of SMV was increased, a 
concomitant rise in O.D. readings was also seen (Figure 6). 
This reaction, however, was not as strong as that observed 
between SMV and the rabbit anti-SMV Ab positive controls. 
When anti-idiotope Abs 2 and 3 were reacted with SMV 
coated wells, a much smaller rise in absorbency readings was 
observed (Figure 7), suggesting a weaker interaction. 
Reactivity of Anti-Sl Idiotope Abs with 
SMV and Other Viruses 
The reactivity of anti-Sl idiotope Abs 1, la, 2 and 3 
with several different plant viruses and the NDV animal virus 
are presented in Table 3 (results are the average of dupli­
cate readings obtained for one experiment). Surprisingly, NDV 
Figure 5. ELISA results for competition assays between SMV 
and biotinylated SI for bound anti-Si idiotope Abs 
Sets o f  mi croti ter wells were coated with 50 jjI o f  
either anti-Sl idiotope Ab la (1:4000 dilution of 
ascites), anti-Sl idiotope Ab 2 (1:2000 dilution 
of ascites) or anti-Sl idiotope Ab 3 (1:4000 
dilution of ascites). Twenty-five ng of 
biotinylated SI McAb was added to each well. 
Immediately following the addition of SI, SMV was 
added to each set of wells in concentrations 
ranging from 0 to 1.000 Mg per well. Results are 
expressed in terms of percent inhibition of 31 
idiotope/anti-idiotope interaction effected by 
competing SMV, Figure represents the results from 
one of duplicate experiments performed. 
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Figure 6. ELISA results for interactions between anti-Sl 
idiotope Abs and bound SMV 
Concentrations of SMV ranging from 0 to 5.0 jjg 
were used to coat sets of microti ter wells. Fifty 
jjl of either SMV Ab (1.0 jug per ml) or anti-Sl 
idiotope la, 2 or 3 (1:1000 dilution of ascites) 
was added to a set of SMV coated wells. Results 
are expressed in terms of absorbancy readings 
obtained for each anti-idiotope Ab with varying 
coating concentrations of SMV. 
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reacted more strongly with the various anti-idiotope Abs than 
did the plant viruses. Anti-idiotope Ab 2, in fact, reacted 
with NOV but did not react with any of the plant viruses. 
Table 3. Anti-SI idiotope Ab interactions with plant and 
animal viruses 
a 
Coating reagent Anti-idiotope ascites 
1 la 2 3 
SMV 0. 32 0, .32 0. 00 0. ,10 
MDMV-A 0. 26 0. 24 0. 00 0. ,11 
BYDV-RPV 0. 38 0. ,46 0. 00 0. ,10 
LMV 0. 40 0. ,42 0. 00 0. 06 
NOV 0. 84 0. ,92 0. 40 0. 14 
TMV 0. 33 0. 41 0. 03 0. 11 
BWB 0. 35 0. 37 0. 01 0. 09 
a 
O.D. readings. 
For anti-idiotope Abs 1 and la, stronger reactions were 
noted with TMV, BYDV and LMV than with SMV. Plates were 
coated with 0.1 jug of virus per well. At this concentration, 
SMV was not recognized by anti-idiotope Abs 1 and la since the 
interaction between 1 or la with the control BWB was greater 
than that with SMV. As far as SMV is concerned, these results 
agree with the results reported in the previous section where 
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la was only able to interact with SMV when SMV was used to 
coat wells at concentrations exceeding 0.2 pg (Figure 6). 
Anti-idiotope Ab 3 did not preferentially react with any one 
of the plant viruses since similar orders of magnitude were 
seen for all of its interactions with virus. 
Reactivity of Rabbit Anti-SMV Abs with 
Anti-idiotope Ab la Coated Plates 
Rabbit anti-SMV polyclonal Abs (0.25 to 1.0 jjg per well) 
reacted with anti-idiotope Ab la (optimum dilution 1:1000 to 
1 : 2000) coated microti ter wells while rabbit anti-TRSV 
polyclonal Abs (1.0 jug per well) did not (Figure 7). Rabbit 
anti-BYDV polyclonal Abs also failed to react with la (data 
not shown). 
Neither SMV Abs nor TRSV Abs appeared to interact with 
anti-idiotope Abs 1, 2, 3 or AB9 when the latter were used as 
well coating reagents. Although various coating dilutions 
(1:1 to 1:2048) were tried for these anti-idiotope Abs, no 
preferential interactions with either SMV Abs or TRSV Ab could 
be detected. 
Competition Between SMV and SMV Ab for 
Bound Anti-idiotope Ab la 
SMV inhibited the interaction between SMV Ab and bound la 
anti-idiotope Ab (Figure 8). Regardless of whether SMV Ab was 
Figure 7. ELISA results for the interactions between SMV Ab 
or TRSV Ab and bound anti-Sl idiotope Ab la 
Sets of microtiter wells were coated with varying 
dilutions (1:200 to 1:256,000) of anti-idiotope Ab 
la ascites. SMV Ab (0.25, 0. 50 ot 1.00 jjg) or 
TRSV Ab (1.00-ug) was added to sets of la coated 
wells. Results are expressed in terms of 
absorbancy readings obtained for the interactions. 
Figure represents the results from one of 
duplicate experiments performed. 
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Figure 8. ELISA results for competition assays between SMV 
and SMV Ab for bound la 
Microti ter wells were coated with anti-Sl idiotope 
Ab la (1:1000 dilution of ascites). One or 0.5 ^ g 
of SMV Ab was added to each well. Immediately 
following the addition of SMV Ab, SMV was added to 
each set of wells in concentrations ranging from 0 
to 2.000 jjg per well. Results are expressed in 
terms of percent inhibition of SMV Ab/anti-
idiotope interaction effected by competing SMV. 
Each data point represents the average of 
duplicate readings from one experiment. 
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used at a constant concentration of 0.5 or 1.0 jug per well, 
the interaction between SMV Ab and la depended upon the 
concentration of SMV. When the concentration of SMV was 
increased, the interaction between SMV Ab and la was inhibited 
to a greater degree. 
Competition Between SI and SMV Ab for 
Bound Anti-idiotope Ab la 
SI inhibited the interaction between SMV Ab in solution 
and anti-idiotope la Ab bound to wells (Figure 9). At SMV 
Ab concentrations of either 0.05 or 1.0 jug per well, 
increasing SI concentrations caused a reduction in the 
interaction between SMV Ab and la. The maximum inhibition 
observed occurred at SI competing concentrations of 2.0 oig per 
well. Depending on the SMV Ab concentration used, 60 to 69% 
maximum inhibition was observed. 
Interaction Between Biotinylated SI and Bound SI 
Biotinylated SI reacted specifically with SI coated wells 
(Figure 10). As SI coating concentration was increased, the 
interaction with biotinylated SI was stronger as evidenced by 
an increase in O.D. readings. 
Biotinylated SI also interacted to a much lesser extent 
with the IgG2a molecules NDV4F11 and MAGI I (Figure 10). It 
did not react with all IgG2a molecules, as evidenced by its 
Figure 9. ELISA results for competition assays between SI 
and SMV Ab for bound la 
Microti ter wells were coated with anti-Sl idiotope 
Ab la (1:1000 dilution of ascites). One or 0.05 
;jg of SMV Ab was added to each well. Immediately 
following the addition of SMV Ab, SI McAb was 
added to each set of wells in concentrations 
ranging from 0 to 2.000 j jg per well. Results are 
expressed in terms of percent inhibition of SMV 
Ab/anti-idiotope Ab interaction effected by 
competing SI McAb. Each data point represents the 
average of duplicate readings from one experiment. 
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Figure 10. ELISA results for the interaction between 
biotinylated SI and bound SI 
Microtiter wells were coated with varying 
concentrations (0 to 2.5 ug per well) of SI McAb. 
Control wells were coated with similar 
concentrations of either SMV, ND\/4F11, l\IDV3H4 or 
MAGII. Four hundred ng of biotinylated SI was 
then added to each well. Results are expressed 
in terms of absorbancy readings obtained for the 
interactions. Figure represents the results from 
one of duplicate experiments performed. 
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failure to react with NDV3H4 (Figure 10). However, the 
interaction between biotinylated SI and SMV was stronger than 
any of the biotinylated Sl/IgG2a interactions. 
Competition Between Biotinylated SI and SMV for Bound SI 
Neither SMV nor the negative control TMV inhibited the 
interaction between biotinylated SI and bound SI in ELISAs 
(Figure 11). In fact, as SMV concentration was increased, 
O.D. readings rose, suggesting a stronger interaction between 
biotinylated SI and SI. It would appear that, in this case, 
SMV actually enhanced the biotinylated SI/SI reaction. 
Competition Between SMV and Anti-idiotope 
A4D for Bound SMV Ab 
The interaction between soluble anti-idiotope Ab A4D and 
SMV Ab bound to microti ter wells was inhibited by SMV (Figure 
12). SMV successfully competed with A4D for bound SMV Ab, as 
indicated by a reduction in the interaction between A4D and 
SMV Ab. Anti-idiotope Ab A4D did not recognize TRSV Ab 
(Figure 12), and the interaction between A4D and SMV Ab was 
not inhibited by TRSV. 
Figure 11. ELISA results for competition assays between 
biotinylated SI and SMV for bound SI 
Microtiter wells were coated with 500 ng of SI 
McAb. One hundred ng of biotinylated SI was then 
added to each well. Immediately following the 
addition of SI, either SMV or TMV was added to a 
set of wells in concentrations ranging from 0 to 
lOjjg per well. Results are expressed in terms of 
percent inhibition of biotinylated SI/SI 
interactions effected by competing SMV. Each data 
point represents an average of four individual 
readings from one experiment. 
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Figure 12. ELISA results for competition assays between SMV 
and anti-idiotope Ab A4D for bound SMV Ab 
Microti ter wells were coated with 50 ng of SMV 
Ab. Varying concentrations (0 to 2.000 jjg per 
well) of either SMV or TRSV were added to sets of 
wells. One hour following the addition of virus, 
A4D hybridoma medium was added to each set of 
wells. Results are expressed in terms of percent 
inhibition of the A4D/SMV Ab interaction by 
competing virus. Figure represents the results 
from one of duplicate experiments performed. 
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Reactivity of Rabbit Anti-SMV Ab 
with A4D Coated Plates 
Rabbit anti-SMV Abs (0.25 to 0.50 xig per well) interacted 
specifically with A4D ascites coated microti ter wells while 
rabbit anti-TRSV Abs (0.50 jug per well) did not (Figure 13). 
As the A4D coating concentration was decreased, there was a 
corresponding decrease in the interaction between SMV Ab and 
A4D. Similar assays using other rabbit polyclonal Abs were 
not performed. 
The interaction between SMV Ab and A4D was weak. A 
maximum O.D. reading of 0.18 was obtained only when wells were 
coated with undiluted A4D ascites fluid (Figure 13). 
Competition Between Anti-idiotope Ab A3A 
and SMV for Bound SMV Ab 
SMV inhibited the interaction between solid phase bound 
SMV Ab and A3A in solution. TRSV failed to inhibit this 
reaction (Figure 14). A maximum inhibition of 73% was 
observed at an SMV concentration of 2.0 jjg. 
Although A3A interacted with bound TRSV Ab, this 
interaction was not inhibited by SMV or TRSV by more than 20% 
(Figure 14). 
Figure 13. ELISA results for the interaction between SMV Ab 
or TRSV Ab and bound A4D 
Microti ter wells were coated with varying 
dilutions (undiluted to 1:1024) of ascites 
containing anti-idiotope Ab A4D. Either SMV Ab 
(0.25 or 0.50 jug) or TRSV Ab (0.50 ojg) was added 
to a set of wells. Results are expressed in 
terms of absorbancy readings obtained for the 
interactions. Figure represents the results from 
one of duplicate experiments performed. 
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Figure 14. ELISA results for competition assays between SMV 
and anti-idiotope Ab A3A for bound SMV Ab 
Microti ter wells were coated with 50 ng of either 
SMV Ab orTRSV Ab. Varying concentrations (0 to 
2.000 <ug per well) of either SMV or TRSV were 
added to sets of wells. One hour after the 
addition of virus, A3A hybridoma medium was added 
to a set of wells containing the various combi­
nations of virus and Ab. Results are expressed 
in terms of percent inhibition of the A3A/SMV Ab 
interaction effected by competing virus. Figure 
represents the results from one of duplicate 
experiments performed. 
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Anti-idiotope Ab I sotype Characterization 
Use of the Zymed-EIA isotyping kit depends on binding of 
the antigen, such as a virus, to a microti ter plate. The 
plate is blocked and washed, and hybridoma medium containing 
mouse Ab to the antigen is added. After the mouse Ab 
interacts with the antigen, rabbit anti-mouse isotype Abs are 
added. Goat anti-rabbit Abs conjugated to an enzyme are then 
added to detect rabbit anti-mouse isotype Abs bound to the 
mouse Abs. 
In this study, mouse hybridoma Abs were produced against 
rabbit Abs. Because rabbit Abs served as the antigen, they 
could not be used to coat the microtiter plates since the 
goat anti-rabbit conjugate would react positively with all 
wells. 
To circumvent this problem, it was necessary to use a 
modified isotyping procedure included in the Zymed-EIA kit. 
Wells were coated with goat anti-mouse Abs for the purpose of 
capturing mouse Abs from hybridoma medium. Isotyping was then 
completed according to the regular protocol. 
Unfortunately, problems were still incurred with 
characterization of anti-idiotope Abs. Because many of the 
hybridoma Abs were not allowed to react specifically with SMV 
Ab and because many of the hybridomas were not cloned, all 
Abs from a particular tissue culture well, whether specific 
for SMV Ab or not, were captured and detected by the isotyping 
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kit. Therefore, many of the results presented in Table 4 are 
not necessarily accurate. Although many of the tissue culture 
wells appeared to harbor more than one class or subclass of 
isotype Ab, several predominant isotypes were expressed by 
mouse hybridoma Abs to SMV Ab. Apparently, IgG3 and IgM Abs 
were more prevalent than other isotype Abs (Table 4). 
Excluding B3A4B and B3A5E, the predominant light chains were 
of the kappa variety. 
When anti-idiotope Abs 2 and 3 in ascites were isotyped 
along with mouse hybridoma Abs to SMV Ab, they appeared to be 
IgM Abs with kappa light chains (Table 4). Anti-idiotope Abs 
1, la and AB9 were never isotyped with the Zymed isotype kit. 
However, the fact that Sigma goat anti-mouse IgM conjugates 
reacted with these anti-idiotope Abs suggests that they are 
IgM Abs. 
Anti-idiotope Ab Inhibition of SMV 
Local Lesion Formation 
The application of anti-idiotope hybridoma medium to 
detached bean leaves 3.5 hours prior to the application of SMV 
infected leaf sap inhibited SMV local lesion formation by at 
least 64% (A4D) (Table 4, Figure 15). Maximum inhibition of 
SMV local lesion formation by an anti-idiotope Ab was 89% 
(A3A). 
Although control treatments were always performed on the 
Figure 15. Anti-idiotope Ab inhibition of SMV lesion 
formation in detached Top crop bean leaves 
Leaf halves were first mechanically inoculated 
with either buffer (Buff), SP2/0 medium or anti-
idiotope Ab hybridoma medium. SMV infected leaf 
sap was then equally applied to both halves of 
each leaf. Each leaf half inoculated with 
hybridoma medium is indicated by its 
representative alphanumeric. 
103 
Buff:SP2/0 C u f f :Buff 
B u f f : B 3 A 5 E  B u f f  : A 3 A  
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Table 4. Hybridoma Ab isotype and inhibition of SMV lesion 
formation on Top crop bean leaves 
a b c  d  
Hybridoma Isotype Control Treated Percent 
Ab Inhibition 
A3A G3, kappa 19 2 89 
A4D M, kappa 28 10 64 
B3A - 26 8 69 
B3A4B M, 1ambda 19 20 - 5 
B3A5E G3, M, lambda 17 2 88 
B3A7F G3, kappa 74 13 82 
C6A M, kappa 22 3 86 
SP2/0 + 
10% serum 
- 15 18 - 20 
SP2/0 + 
20% serum 
f 
SMV 
G31 kappa 22 
20 
11 
40 
50 
a 
Isotypes which gave the highest O.D. reading when more 
than one isotype was detected. 
b 
Total number of lesions formed on the left halves of 6 
leaves inoculated with phosphate buffer and SMV. 
c 
Total number of lesions formed on the right halves of 5 
leaves inoculated with phosphate buffer, SMV and hybridoma 
medi um. 
d 
Per cent inhibition = Control - Treated x 100. 
Control 
e 
B3A4B, B3A5E and B3A7F hybridoma media contained only 
10% serum. All other hybridoma media contained 20% serum. 
f 
Each half of each leaf was identically inoculated with 
SMV and phosphate buffer. 
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left halves of the leaves and experimental treatments were on 
the right halves, the inhibition of SMV local lesions did not 
favor the right halves (Table 4). 
Medium devoid of Abs (SP2/0 with 20% serum) apparently 
inhibited SMV local lesion formation by 50%. However, when 
the serum concentration in the medium was reduced to 10%, no 
inhibition occurred. 
Medium containing Abs which were not specific for SMV Ab 
(B3A7F) (Table 2) inhibited local lesion formation by 82% 
(Table 4). 
Ascites containing anti-idiotope Abs 2 or 3 inhibited 
local lesion formation by approximately 27 to 29% when 
compared with the virus control. Anti-idiotope Ab la, on the 
other hand, apparently enhanced lesion formation by as much as 
500% (Table 5). In contrast, no difference was seen between 
anti-idiotope Abs la and 2 when compared with each other on 
the same leaf. However, when la was compared with 3, the la 
inoculated leaf half showed nearly twice as many lesions (data 
not shown). 
Although the results presented in Table 5 for anti-
idiotope Abs 2 and 3 versus virus were compiled from two 
separate experiments, the ratios of the number of local 
lesions formed on the control (virus) versus the treated (anti-
idiotope ascites) leaf halves for the two experiments were 
comparable. 
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Table 5. Anti-Sl idiotope Ab inhibition of SMV local lesion 
formation 
a b c 
Treatment/ Treatment/ Lesions on Percent 
left right left/right inhibition 
SMV SMV + la 1/6 -500.0% 
SMV SMV + 2 22/16 27.3% 
SMV SMV + 3 21/15 28.6% 
a 
Left halves of leaves were inoculated with SMV diluted 
in buffer. 
b 
Right halves of 2 leaves were inoculated with anti-
idiotope Ab (la, 2 or 3) followed by SMV diluted in 
buffer. 
c 
Percent inhibition = Left - Right x 100. 
Left 
Production of IgG Abs by Rats Injected with 
Anti-idiotope Abs la or 3 
An ELISA was used to determine the pre-immune (normal 
serum) and post-immune IgG response in rats injected with anti-
idiotope Abs la or 3. The results of this assay are sum­
marized in Table 6 and represent one of duplicate experiments 
yielding similar results. It was assumed that a positive IgG 
Ab response to any of the reagents listed in Table 6 would be 
reflected by lower O.D. readings for normal serum as compared 
to post-immune serum. 
Fisher 344 rats produced IgG Abs to anti-idiotope Abs la, 
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2 and 3. They also produced IgG Abs to SI and NDV4F11, though 
to a lesser degree. No IgG Ab response to SMV was detected. 
In fact, pre-immune sera had a greater IgG anti-SMV response 
than post-immune sera. 
In a similar comparison, Long Evans rats injected with 
anti-idiotope Ab la produced a strong IgG Ab response to SI 
and NDV4F11 and to anti-idiotope Abs la, 2 and 3. These same 
rats also produced a small but detectable IgG response to SMV. 
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Table 6. Production of IgG Abs in rats injected with either 
anti-Si idiotope Ab la or 3 
Normal 
Second 
Third 
Anti- Bleeding 
idiotope 
inoculurn SMV 
0.67 
0 . 2 8  
0.13 
1 a 
Coating reagent 
2 3 SI 
0.90 
1.70 
1. 70 
0.64 
1.09 
1 . 1 8  
0 . 8 0  
1 . 6 6  
1 . 6 2  
1 . 1 0  
1 . 1 0  
1 . 1 0  
NDV4F11 
1.46 
1.63 
1.55 
Normal 
Second 
Third 
0.51 
0.50 
0 . 2 0  
0. 53 
1.70 
1.70 
0.29 
0.98 
0.90 
0.42 
1.43 
1 .37 
0.76 
0.95 
1 . 1 0  
1.23 
1.34 
1.29 
la 
Normal 
Second 
Third 
Fourth 
0.29 
0.37 
0.62 
0.40 
0.31 
1.70 
1.70 
1.70 
0 . 1 2  
1.39 
1 . 8 1  
1.92 
0 . 1 8  
1.98 
1.93 
2.05 
0.37 
1 . 1 0  
1 . 1 0  
1 . 1 0  
0.83 
1.55 
1 . 8 0  
1 . 8 0  
1 a 
Normal 
Second 
Th i rd 
Fourth 
0.43 
0.84 
0.48 
0.38 
0.58 
1.49 
1.49 
1.19 
0.44 
1.91 
1.91 
0.40 
1.97 
1.97 
1.97 
0.36 
0.95 
0.95 
0.95 
0. 53 
1.56 
1.56 
1.56 
a 
O.D. readings. 
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DISCUSSION 
A major portion of this study was concerned with the 
production and characterization of anti-idiotype McAbs to 
mouse monoclonal (SI) Abs or to rabbit polyclonal Abs to SMV. 
As with most syngeneic systems reported (115), the 
generation of anti-idiotype Abs to SI in the syngeneic 
system under study proved to be a difficult task. This was 
evidenced by the fact that the serum from only one of the five 
Balb/c mice injected with SI hybridomas contained Abs which 
interacted with biotinylated Si in ELISAs. 
Fewer difficulties were encountered in the generation of 
an immune response when mice were injected with rabbit 
polyclonal Abs. Serum from all three mice injected with 
rabbit TRSV Abs or SMV Abs contained Abs which reacted with 
the immunizing Abs in ELISAs. Although cyclophosphamide was 
used in conjunction with TRSV Abs to suppress the mouse immune 
response to common rabbit Ab epitopes, the rabbit Abs 
apparently were sufficiently immunogenic to override the 
suppressive effects of the chemical. This was quite evident 
in view of the fact that a majority of hybridomas generated to 
SMV Abs produced Abs which reacted in ELISAs with TRSV Abs 
rather than with SMV Abs. 
A number of problems were also encountered in the 
characterization of anti-idiotope Abs. Characterization of 
such Abs is usually based on: 1) their interaction with CRIs 
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on intraspecies and interspecies Abs; 2) their interactions 
with idiotope presenting Abs (e.g., SI) in the presence of a 
competing antigen (e.g., SMV); and 3) their i_n v i vo biologi­
cal activity. In this study, anti-idiotope Abs 1, la, 2, 3 
and AB9 interacted with bound SI in ELISAs (Figure 1). They 
appeared to recognize SI in ELISAs since, as the SI coating 
concentration was decreased, there was a concomitant 
reduction in the reaction between these anti-idiotope Abs and 
SI. 
Anti-idiotope Abs la, 2 and 3 also interacted with 
idiotope(s) on NDV4F11 while anti-idiotope Abs 1 and AB9 did 
not (Table 1). None of the anti-idiotope Abs interacted with 
NDV3H4; therefore, these results cannot be due to anti-
isotype interactions since SI, MAGII, NDV4F11 and WDV3H4 are 
all IgG2a kappa light chain molecules. 
Although SI, MAGII and NDV4F11 recognize different 
antigens, the results from this study suggest that they share 
CRIs. Since anti-idiotope Abs la, 2 and 3 recognized NDV4F11 
while anti-idiotope Abs 1 and AB9 did not, and since all 
five anti-idiotope Abs recognized SI, it is possible that 
there is more than 1 CRI on SI,.MAGII and NDV4F11. 
With the exception of B3A7F, SMV interfered with the 
interactions between the hybridoma Abs listed in Table 2 and 
SMV Abs. This interference indicates that the epitopes 
recognized by these hybridoma Abs were closely associated 
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with SMV Ab paratopes. Since the idiotype of an Ab molecule 
is associated with its paratope, it is probable that the 
hybridoma Abs (Table 2) recognized idiotopes on SMV Ab 
molecules. Therefore, these hybridomas were designated as 
anti-idiotope hybridomas even though they recognized epitopes 
on both TRSV Ab and SMV Ab. These epitopes are probably 
CRIs. The fact that anti-Sl idiotope Abs (Table 1) and the 
anti-idiotope Abs (Table 2) recognize CRIs is not surprising 
since intraspecies Ab CRIs have been reported for other 
antigen/Ab systems (2, 8, 9, 10, 13, 40, 65, 66, 76, 95). 
Abs generated by the A4D hybridoma in tissue culture 
medium were relatively specific for SMV Ab, interacted poorly 
with TRSV Abs and were inhibited from interacting with SMV 
Abs by SMV. However, A4D Abs generated in ascites (A4Dasc) 
reacted strongly with TRSV Abs. SMV did not inhibit, but 
apparently enhanced, the A4D/SMV Ab interaction (Table 2), 
much like that observed with the SI/anti-Sl idiotope Ab la 
interaction (Table 1). Since A4D was not cloned, this change 
in A4D specificity may reflect the appearance of an Ab-
producing hybridoma which grew slowly and remained silent in 
tissue culture medium, but which grew well and expressed 
itself during A4D ascites production in mice. 
It is also possible that the apparent change in A4D 
specificity may reflect a change in the A4D hybridoma since 
it has been demonstrated that passage of hybridomas in 
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ascites can alter the specificity of the McAb produced by the 
hybridoma (114). 
Anti-idiotope Ab la interacted with SMV Ab but failed to 
interact with TRSV Ab or BYDV Ab. Anti-idiotope Abs 1, 2, 3 
and AB9 did not exhibit these same features (Table 1), The 
interaction between la and SMV Ab appears to be specific. 
This feature becomes apparent in ELISAs where constant 
concentrations of SMV Ab are allowed to interact with varying 
concentrations of la. As the concentration of la is 
decreased, the interaction between SMV Ab and la also 
decreases as reflected in lower O.D. readings (Figure 7). 
SI and SMV Ab apparently share a CRI since they compete 
with each other in ELISAs for bound la (Figure 9). This CRI 
may be relatively close to the paratope of the SMV Ab since 
SMV competes with SMV Ab for bound la (Figure 8). Such 
interspecies CRIs have been described for other antigen/Ab 
systems (13, 75, 78, 81, 95, 102, 117, 125). 
Anti-idiotope Abs 1, la, 2, 3 and AB9 recognize an 
idiotope near the paratope of SI (Figures 3 and 4) and anti-
idiotope Abs A3A and A4D recognize an idiotope near the 
paratope of SMV Abs (Figures 12 and 14). These conclusions 
are based on the observation that SMV competes with these 
anti-idiotope Abs for their respective idiotype Abs in 
ELISAs. 
Two-fold increases in SMV concentration inhibited the 
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A4D/SMV Ab and A3A/SMV Ab interactions in a linear fashion 
(Figures 12 and 14). However, similar inhibition was not 
observed for the Si/anti-SI idiotope Ab interactions (Figures 
3 and 4). 
Although the SMV inhibition curves generated for the 
SMV Ab/anti-idiotope Ab interactions (Figures 12 and 14) are 
different from the curves generated for the SI/anti-idiotope 
Ab (excluding anti-idiotope Ab 2) interactions (Figures 3 and 
4), these differences are probably not due to SMV stearic 
hindrance. This conclusion is based on the fact that intact 
SMV was used for both types of competitive assays. 
Based on the following evidence, differences in the SMV 
inhibition curves generated for the SMV Ab/anti-idiotope Ab 
and the SI/anti-idiotope Ab systems could be due to the type 
of inhibition assay used to demonstrate competition between 
the reactants. The SMV Ab/anti-idiotope Ab assays involved a 
sequential SMV/anti-idiotope Ab competition assay while the 
SI/anti-idiotope Ab assay involved a simultaneous SMV/anti-
idiotope Ab competition assay. When a simultaneous 
competition assay was performed with the SMV Ab/anti-idiotope 
Ab system, competition between SMV and anti-idiotope Ab for 
bound SMV Ab could not be demonstrated. 
Differences in these SMV inhibition curves could also be 
due to differences in affinities which SMV and anti-idiotope 
Abs have for bound idiotope Ab (78) or for each other. 
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Evidence supporting the contention that SMV and anti-
idiotope Abs demonstrate affinity for each other stems from 
the results obtained from the following assays. 
In the competition assay where SMV was used to inhibit 
the interaction between biotinylated SI and bound anti-
id iotope Ab, there was slight inhibition between SI and anti-
idiotope Abs 2 or 3. The interaction between SI and anti-
idiotope Ab la, however, was enhanced (negative inhibition). 
It would appear that bound anti-idiotope Ab la captured 
biotinylated 31 and SMV which, in turn, captured biotinylated 
SI (Figure 5 ). 
In the second assay, when SMV was used to coat ELISA 
plates, anti-idiotope Ab la, and to a limited extent, anti-
idiotope Ab 3, reacted with SMV while anti-idiotope Abs 2 
(Figure 4) and A4D (data not shown) did not. 
The SMV inhibition curves for the interactions between 
SI and anti-idiotope Ab la or 3 were non-linear while those 
for the SMV Ab/anti-idiotope Ab 2 or A4D interactions were 
linear within the SMV concentration ranges used. These 
fluctuations in response to competing SMV may reflect 
differences in the affinities which the anti-idiotope Abs 
have for SMV. Anti-idiotope Ab la has an apparent affinity 
for and reacts with both the Si idiotype Ab (Figure 3) and 
the SMV antigen (Figure 6). This type of anti-idiotope Ab 
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has been described previously and is referred to as an 
epibody (7, 8, 19). 
It is interesting to note that anti-idiotope Ab la may 
also recognize several other plant viruses and an animal 
virus (Table 3). The reason for this is unclear. However, 
it has been postulated that an Ab may have more than one 
antigen-binding site. Theoretically, neighboring idiotopes 
on an Ab molecule, which are probably separated by clefts and 
are likely to form protuberances, may act as antigen binding 
sites. Consequently, an Ab molecule may have the potential 
to be multispecific (48, 60) and may exhibit these extra 
binding sites or mi ni-paratopes. 
If mi ni-paratopes do exist on Ab molecules, then this 
could explain the multispecificity of other Abs (46, 105) and 
la with seemingly unrelated ligands. 
The specific rabbit polyclonal Ab binding character­
istics displayed by the Abs generated in ascites fluid by 
hybridoma A4D (Table 2) were similar, although not identical, 
to those of anti-idiotope Ab la (Table 1). Unlike la, anti-
idiotope Ab A4Dasc reacted rather strongly with bound TRSV Ab 
(Table 2). However, when A4Dasc Abs were bound to microti ter 
wells, they interacted with SMV Abs but not with TRSV Abs 
(Figure 13). 
The A4D hybridoma was not cloned. Therefore, it is 
possible that an anti-TRSV Ab may have been present in the 
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A4D ascites fluid which could interact with bound TRSV Abs 
but could not bind to microtiter wells to capture TRSV Abs in 
solution. 
It is also possible that the same A4D hybridoma Ab 
responsible for SMV Ab binding was also responsible for TRSV 
Ab binding. However, when A4Dasc Abs were used to coat 
microtiter wells, the A4Dasc Ab binding site responsible for 
anti-TRSV Ab activity may have been occluded. Such changes 
in an Ab's activity, brought about by attachment of the Ab to 
a solid phase, have been reported for other antigen/Ab 
systems (54, 118). 
Anti-idiotope Abs to either SMV Abs or to SI did exhibit 
some biological activity. In plant assays, hybridoma medium, 
which contained either anti-idiotope Ab A4D, B3A, B3A5E, C6A 
or A3A, inhibited SMV local lesion formation on detached 
leaves by 64 to 89% (Table 4, Figure 15). Dr. John Hill has 
recently performed a leaf assay using B3A5E hybridoma medium 
to inhibit SMV lesion formation on 25 leaves. In his assay, 
B3A5E inhibited lesion formation when compared to the SP2/0 
control medium (personal communication). 
Based on the results presented in Table 4, it is 
difficult to determine whether these anti-idiotope Abs a re 
mimicking SMV and preventing local lesion formation by 
interacting with putative SMV receptors. Antibody-free 
medium (SP2/0 with 20% serum) inhibited SMV local lesion 
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formation by 50% (Table 4). Medium from B3A7F (a clone of 
B3A) inhibited local lesion formation by 82% (Table 4), yet 
B3A7F did not interact with either SMV, SMV Ab or TRSV Ab in 
ELISAs (Table 2). Since the light and heavy chains of an Ab 
constitute its paratope, and since the light chain and the 
binding characteristics of B3A5E differ from those of B3A7F 
(Table 2), the failure of B3A7F to interact with SMV, SMV Ab 
or TRSV Ab may be due to its light chain. If its light chain 
is responsible for its binding characteristics in ELISAs, it 
is also possible that the SMV mimicking portion of the B3A7F 
molecule is associated with its heavy chain variable region. 
The Zymed isotyping kit did indicate that molecules 
bearing IgG3 and kappa light chain characteristics were 
present in both SP2/0 and B3A7F media which contained 
20% and 10% serum respectively (Table 4). SP2/0 medium with 
10% serum lacked these molecules and did not inhibit SMV 
local lesion formation (Table 4). It should be noted here 
that the serum source used in this study was not globulin 
free and may have contained molecules with characteristics 
similar to mouse IgG3 Abs. 
The high efficiency with which B3A7F inhibited SMV local 
lesion formation, compared with SP2/0 medium, could be due to 
either its mimicking of SMV or to the concentration of the 
IgG3 kappa molecules. When the hybridoma medium was iso-
typed, the concentration of these molecules was slightly 
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higher in B3A7F than in SP2/0 medium. 
Hybridoma medium from A3A, C6A, A4D and B3A5E which also 
contained IgGS molecules, inhibited SMV lesion formation to a 
much greater extent than SP2/0 medium (Table 4). It is quite 
possible that these Abs are mimicking SMV or that the 
effector region responsible for inhibiting SMV local lesion 
formation is on a mouse IgGS molecule. Since B3A7F inhibited 
SMV lesion formation but did not interact with SMV Abs, it is 
also possible that any mouse Ab with IgG3 characteristics, 
and not just an anti-idiotope Ab, may inhibit SMV lesion 
formation. It is also possible that biological features 
displayed by Abs of other isotypes may influence SMV lesion 
formation. However, since anti-idiotope Abs displaying 
isotypes other than those presented in Table 6 were not 
generated in this study, this possibility was not explored. 
Cells grown in tissue culture can spontaneously release 
viral inhibitors which prevent virus attachment, penetration 
and replication in cells (7). It is unlikely that similar 
SMV inhibitors are produced by the established cells in this 
study since medium from SP2/0 cells which contained WZ serum 
failed to inhibit SMV lesion formation (Table 4). 
In comparison to the anti-idiotope Abs listed above, 
anti-idiotope Abs 2 and 3 from ascites exhibited a much lower 
inhibitory capability when assayed against the PBS control 
(Table 5). 
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When compared to the PBS control and to anti-idiotope Ab 
3, la enhanced SMV lesion formation. However, in contrast to 
the data shown in Table 5, when anti-idiotope Abs 2 and la 
were compared with each other on the same leaf, no difference 
was seen in the ability of la to influence SMV lesion forma­
tion (data not shown). The anti-SI IgM titer in mouse la 
ascites is approximately equal to the anti-SI IgM titer in 
mouse anti-idiotope Ab 2 ascites and greater than in mouse 
anti-idiotope Ab 3 ascites (Figure 3). It is possible that 
IgM titer alone may affect SMV lesion formation. 
The comparisons between anti-idiotope Abs la, 2 and 3 
were performed only once using two leaves for each comparison 
and the number of SMV lesions that developed was small. 
Therefore, it is difficult to determine whether or not la 
enhanced SMV lesion formation in comparison to the controls 
or to other anti-idiotope Abs. However, la may have the 
potential to enhance SMV lesion formation in plants. Anti-
idiotope Ab la seems to mimic SMV and stimulate anti-SMV Ab 
production in rats (Table 6). It also recognizes SMV in 
ELISAs. The enhancement phenomenon observed with la in the 
SMV inhibition assay may possibly be due to the binding of 
its SMV mimicking portion to a putative SMV receptor in the 
plant leaves. When SMV is later applied to the leaf, recep­
tor bound la captures SMV, thus increasing the concentration 
of SMV near the putative receptor. This, in turn, would 
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mediate an increase in lesion formation if it may be assumed 
that SMV has a greater affinity for the receptor and 
displaces la. Whether such a scenario actually occurs when 
la is used in an SMV lesion inhibition assay has yet to be 
determi ned. 
To summarize thus far, anti-idiotope Abs to SI in 
ascites were not as efficient as anti-idiotope Abs to SMV Ab 
in tissue culture medium in inhibiting SMV lesion formation 
in detached leaves. Either anti-idiotope Abs to 51 were less 
efficient in inhibiting lesion formation when compared to the 
anti-idiotope Abs to SMV Abs, or components present in tissue 
culture medium, but absent in ascites, inhibited lesion 
formation. 
Anti-idiotope Abs la and 3 did exhibit biological 
activity in rats (Table 6). Fisher 344 rats injected with 
anti-idiotope Ab 3 hybridoma cells and ascites and Long Evans 
rats injected with la ascites produced, as expected, IgG Abs 
to their respective immunogens. These rats also produced IgG 
Abs to other anti-Si idiotope Abs (Table 6). Since the rat 
IgG response varied with the anti-idiotope Ab used to coat 
ELISA plates, it seems likely that these rats responded to 
the anti-idiotope Abs and not to common mouse constituents in 
ascites fluid. This putative response to anti-idiotope Abs 
was not unexpected since anti-idiotope Abs la, 2 and 3 were 
all generated to the SI Ab and thus may share a CRI. It has 
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been shown that in different strains of mice, Abs which were 
specific for different epitopes on a common Ab can share a 
CRI (7). Therefore, it is conceivable that anti-idiotope Abs 
la, 2 and 3 share a CRI which can be immunogenic and which 
can stimulate an IgG response in rats. However, further 
studies are needed to determine if these anti-Si idiotope Abs 
actually do share a CRI. 
Results indicate that la (Ab2) mimics the original SMV 
antigen since Long Evans rats injected with la ascites 
generated IgG Abs (AbS) to SMV. Such Ab2 antigen mimicry has 
also been demonstrated in the TMV immune network system where 
rabbit anti-idiotope Abs (Ab2) to anti-TMV Abs (Abl) elicited 
the production of AbS molecules in mice previously unexposed 
to TMV. As in the SMV system, Ab3 molecules interacted with 
the original antigen TMV (26). 
Long Evans rats injected with la (Ab2) ascites also 
produced IgG Abs to SI (Abl) and to NDV4F11 (Table 6). These 
results were unexpected since the rats made anti-SMV Abs 
(Ab3) which reacted to some extent like SI (Abl) (Figure 10). 
These rat Ab3 molecules should, theoretically, either react 
with SMV or with la (Ab2) and not SI (Abl). There are 
several explanations which could account for the anti-SI 
response in rats injected with la. It is possible that la 
(Ab2) ascites contained syngeneic Balb/c anti-la (Ab3) 
molecules which elicited the production of anti-Sl molecules 
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i-n rats. It is also possible that la (Ab2) turned on the SMV 
immune network in the rats which lead not only to the 
production of anti-SMV (Ab3) molelcules, but also anti-Sl 
molecules. A similar situation involving the BSA immune 
network has been reported (62). In this system, the 
injection of anti-BSA McAb (Abl) elicited an Ab2 response 
which subsequently lead to an anti-BSA (Ab3) response in the 
same animals. A final explanation for the rat anti-Sl IgG 
response is based on the premise that the anti-SMV IgG Abs 
generated by the rats recognized other anti-SMV Abs such as 
SI or were self binding. The concept of Ab self binding has 
been described for Abs referred to as autobodies (52, 53). 
Since the IgG Abs from rats injected with la reacted 
with both SI and SMV, SI was chosen for futher study as a 
model system to determine if an Ab to SMV could exhibit self 
binding properties. Since biotinylated SI interacted with 
bound SI in ELISAs (Figure 10), it would seem that SI was 
self binding. Biotinylated SI also interacted with two other 
IgG2a molecules (NDV4F11 and MAGII) in ELISAs (Figure 10). 
This suggests that it recognized a CRI shared by SI, MAGII 
and NDV4F11. A similar situation has been reported in the 
pneumococcal system where a CRI was recognized by an autobody 
(53). The fact that biotinylated SI did not react with a 
third IgG2a molecule (NDV3H4) suggests that it recognized an 
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idiotope on SI rather than an epitope associated with the 
isotype of an Ab. 
A similar self binding capability may also be possible 
for rat anti-SMV IgG Abs (Ab3) produced 1n response to la. 
Like SI, they reacted presumably with CRIs on SI and NDV4F11. 
Although this possibility was not explored, the rat anti-SMV 
Ab3 molecules may also recognize idiotopes on themselves and 
on SI. 
Fisher 344 rats injected with anti-idiotope Ab3 ascites 
did not produce IgG Abs which reacted appreciably with SI, 
NDV4F11, or with SMV (Table 6). 
Since anti-idiotope Abs la and 3 were respectively used 
to immunize Long Evans rats and Fisher 344 rats, differences 
in the Abs produced by these two strains of rats may reflect 
either differences in the injection protocols used for 
immunization or differences in the genetic makeup of the 
rats. The influence which an animal's genotype may have on 
its immune response to anti-idiotope Abs has been reported 
previously (31, 116). 
It has been shown that the j_n vivo production of 
idiotope bearing Abs is influenced by the specificity of the 
anti-idiotope Ab (54). The SMV competition assays indicate 
that the SI idiotope recognized by anti-idiotope Ab 3 differs 
from that recognized by la (Figure 3). Therefore, it is 
possible that the idiotope specificity of these two anti-
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idiotope Abs is different and thus induces different immune 
responses in rats. 
SI presented a unique set of binding characteristics 
unlike those of the autobody originally described for the 
pneumococcal system (53). In this system, the autobody's 
ability to bind to itself was inhibited by the pneumococcal 
antigen. This indicated that the idiotope recognized by the 
autobody was located very close within the paratope of the 
autobody. 
In the SMV system, the virus antigen failed to inhibit 
the binding of SI to itself. In fact, SI bound to microtiter 
wells evidently captured both biotinylated SI and SMV (Figure 
11). This suggested that the idiotope recognized by SI was 
extraneous to the SI paratope. 
It has been postulated that adjacent idiotopes on an Ab 
molecule may form antigen-binding sites (60) or mini-
paratopes. The results presented in Figure 11 may also 
suggest that the SI/SI interaction may be due to an SI mini-
paratope/S1 idiotope interaction while the S1/SMV interaction 
may be due to an SI paratope/SMV interaction. If this is the 
case, then it is conceivable that the SI/SMV interaction 
could occur without inhibiting the SI/SI interaction. 
The binding of SI to itself and to SMV (Figures 11) 
suggests that SMV may share antigenic characteristics with a 
mouse Ab. If this is true, it could explain some of the 
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results obtained with the SMV local lesion inhibition assay 
where mouse Abs such as B3A7F which, in this study, had no 
anti-idiotypic properties, appeared to mimic SMV and inhibit 
lesion formation on plant leaves (Table 4). 
At this point, it becomes obvious that further specula­
tion on the findings presented in this study cannot be 
justified. The hard evidence needed to substantiate any 
further discussion on the biological aspects of the anti-
idiotope Abs described thus far is lacking. Obviously, 
further research is needed to support or refute the results 
and conclusions presented in this study. 
However, the evidence presented thus far points to the 
potential usefulness for anti-idiotypic Abs in plant virology 
research. Briefly, these Abs or the hybridomas used to 
generate them could be used in the following ways; 1) as 
inexpensive positive controls in ELISAs; 2) as tools for 
studying virus-host interactions; and 3) as possible sources 
of genetic information to confer virus resistance to plants. 
The results, conclusions and conceptions presented in 
this study lend credence to these contentions. An anti-
idiot ope Ab such as la can be used as an inexpensive control 
in ELISAs in lieu of an antigen such as SMV. For instance, 
50 jjl of la ascites fluid diluted 1 :2000 could be used to 
coat an ELISA microti ter well and capture rabbit polyclonal 
SMV Ab (Figure 7) much tike SMV captures the Ab (Figure 6). 
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At such a dilution, 5 mis of la ascites could theoretically 
coat 200,000 wells. 
Most ELISA plant virus detection systems currently use 
rabbit polyclonal Abs. Since it is easier and less expensive 
to generate mouse ascites than it is to purify a plant virus, 
anti-idiotype Abs can be substituted for these viruses and 
thus serve as positive controls in ELISAs. Anti-idiotype Abs 
would also provide much safer controls than quarantined 
exotic plant viruses. 
Anti-idiotype Abs may be useful in studying virus-host 
interactions, in view of the effect which Abs had on SMV 
lesion formation on plant leaves (Table 4). If anti-idiotype 
Abs mimic a plant virus and inhibit viral pathogenesis, then 
these Abs could be used to probe for sites of virus-host 
interaction at the molecular level. If such sites are 
identified in susceptible plants but found to be absent in 
resistant plants, then plant breeders may be able to 
immunologically screen for virus susceptible plants. Since 
plant breeders rely on virus infectivity assays which, in 
some cases, require hard-to-handle virus vectors or costly 
field assays, an immunological assay would be much more 
economically efficacious. 
As a source of genetic information which confers virus 
resistance in plants, it has been demonstrated that viral 
coat protein c-DNA incorporated into a plant genome will 
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delay virus disease development in that plant (1). In a 
similar fashion, the segment of hybridoma DNA which encodes 
for the virus coat protein mimicking portion of an anti-
idiotope Ab could be identified, isolated and incorporated 
into a plant genome to confer virus protection. Since the 
DNA used to confer virus protection via anti-idiotope antigen 
mimicry is of Ab, rather than viral origin, the possibility 
of an outbreak of a novel transencapsidated virus is 
essentially eliminated. 
If it can be demonstrated that biologically active, 
antigen mimicking, hybridoma DNA can be incorporated into a 
plant genome, then this technique could be successfully 
extended to areas of plant science where plant genetic 
engineering via the prokaryotic c-DNA route has not been 
successfu1. 
The results, conclusions and concepts presented in this 
study cannot be considered final. However, they hopefully 
will have provided the intellectual impetus and curiosity 
which is necessary for the continuation of research on SMV 
and the Abs involved in the SMV immune network. 
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